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Abstract 
 
Mechanical ventilation (MV) is one of the most difficult, costly and variably delivered 
therapies for Acute Respiratory Distress Syndrome (ARDS) and respiratory failure patients in 
the intensive care unit (ICU). These patients experience severe widespread breathing 
problems and require MV for breathing support. However, conventional MV does not 
provide enough real-time information to guide or individualize therapy, and suboptimal MV 
settings increase the risk of further lung injury and complications.  
 
In particular, positive end expiratory pressure (PEEP) is applied during MV to aid recovery 
by improving gas exchange and prevent de-recruitment of lung units. However, selection of 
patient-specific, optimal PEEP remains widely debated, as no standard approaches exist for 
setting MV. Clinicians often use general approaches or experience to select PEEP, increasing 
the variability and risk of care, while reducing or eliminating any patient-specific aspect of 
care. Thus, physiological mathematical lung models of respiratory mechanics are required, if 
they are suitable to be used to optimise MV settings to improve critically ill patient outcomes.  
 
The aims of this research are to investigate and develop new, extended models of lung 
mechanics for ARDS and respiratory failure patients. In particular, to create model-based 
measures of the potential impact to healthy lung units of changing MV therapy parameters. 
This goal requires rapid forms of parameter identification to define patient-specific model 
parameters from clinical data that can be used as complementary metrics in guiding and 
individualising MV.  
 
xvi 
 
The first model, an airway branching model (ABM) was developed based on classical fluid 
mechanics models that are commonly used. Typically, they are not feasible for real-time 
applications. Thus, there is a need to develop an accurate, effective, yet simpler, ABM model 
that can be applied at the bed-side. To address this issue, a patient-specific airway branching 
(ABMps) model is developed to measure the airway pressure drop at every physiological 
airway branch with an extended patient-specific physiological dimension that is unique for 
each patient and can evolve over time with new data. With this patient-specific dimension 
(α), the ABMps is able to provide clinical insight on patient-specific physiological 
conditions. Using the retrospective clinical data from the Christchurch Hospital, it was found 
that α ranges from 0.45-0.66 for ARDS patients, which is smaller than normal healthy people 
indicating severity of condition. Hence, the airway condition of a patient can be characterised 
and evolve over time to provide useful patient-specific clinical guidance. 
 
Next, a model using only the expiratory data of the breathing cycle is developed and 
presented that is potentially useful during clinical respiratory mechanics monitoring to guide 
MV. In particular, the expiratory time constant parameter, (K), can provide unique 
information related to respiratory system elastance in MV patients. In this thesis, the 
extended model is tested using clinical data from ARDS patients and investigates the 
relationship between the expiratory time constant and model-based inspiratory respiratory 
system elastance. The goal is to use this relation to titrate patient-specific PEEP, which can 
help prevent the risk of lung over-distension and ventilation-induced injury.  
 
The third model extends the time varying elastance model to investigate the variability of this 
respiratory system elastance for MV patients. In this case, in Christchurch Hospital. With the 
proposed metric, a deeper understanding can be achieved that provides clinicians with more 
xvii 
 
information on how respiratory elastance varies between patients, PEEP, and ventilation time. 
This information is patient-specific and can be updated overtime, as well as used as a marker 
of patient condition.  
 
Estimating respiratory mechanics of MV patients is unreliable when patients exhibit 
spontaneous breathing (SB) efforts on top of any form of ventilator support. Most well-
known developed models are thus only suitable for fully sedated patients. Monitoring 
respiratory mechanics of SB patients requires invasive clinical protocols and equipment that 
are clinically too intensive to carry out. In this research, it was found that the variability of 
lung elastance in SB patients is due to an effective negative elastance produced by the SB 
effort that is created by the SB effort, but cannot be modelled directly. Thus, by extending the 
non-invasive time-varying elastance model to capture negative elastance, it can provide more 
consistent monitoring for SB patients by reviewing the distribution of negative elastance. 
This work thus extends capabilities of these models and quantified the level of SB efforts.  
 
Finally, due to the asynchrony, also known as reverse triggering, airway pressure can assume 
an unusual and unmodelled M-wave shaped airway pressure during the MV. This M-wave 
airway pressure is also due to the SB efforts, exhibited by patients, even when they are fully 
sedated. Hence, a model-based method to reconstruct the affected airway pressure curve is 
introduced that enables estimation of the true underlying respiratory mechanics of these 
patients, as well as quantifying SB efforts. Results show that this pressure wave 
reconstruction method was able to accurately identify the respiratory elastance, assess the 
level of SB effort, and quantify the incidence of SB effort without invasive protocols or 
interruption to care. Hence, this method is clinically useful for clinicians in determining 
optimal ventilator settings to improve patient care. 
xviii 
 
Overall, these tools and methods provide significant new ways to clinically manage MV 
patients in the ICU. Model-based methods offer the opportunity to protocolize and 
individualize care. Thus, the main outcomes of this work provide a step forward towards 
better, more consistent and patient-specific MV. 
 
1 
 
CHAPTER 1 
Introduction 
 
1.1  Acute Respiratory Distress Syndrome (ARDS) 
 
Acute respiratory distress syndrome (ARDS) is a severe form of Acute Lung Injury (ALI), 
where the lung experiences various types of injuries that lead to a respiratory failure. These 
injuries prevent the lung’s ability to exchange gas effectively, resulting in oxygen deficient 
blood, direct alveolar injury, pulmonary oedema and alveolar collapse (Ashbaugh et al. 1967; 
Bernard et al. 1994b; Kattwinkel et al. 2004; Kollef & Schuster 1995). Injuries in the lung 
also cause significant inflammation leading fluid to spill into the lung, resulting in a stiffer 
and smaller lung and reducing the overall lung volume to a so called baby lung (Gattinoni & 
Pesenti 2005; Ware & Matthay 2000). The sequel to all these effects is failure to deliver 
oxygen to other organs and tissues leading to further organ failure and increased risk of death.  
 
The cause of ARDS can be either direct or indirect. For example, pulmonary aspiration/near 
drowning, pneumonia, and smoke inhalation are several types of direct lung injury that can 
lead to ARDS. Similarly, ARDS can also be caused indirectly through the inflammatory 
response and stress due to sepsis, severe trauma to other body parts circulating fluid 
resuscitation , or massive blood transfusion (Burleson & Maki 2005; Ware & Matthay 2000).  
 
ARDS was first described in 1967 (Ashbaugh et al. 1967) and, since then, the definition of 
ARDS has evolved and varied until it was redefined in 1994 by the American-European 
Consensus Conference (AECC) (Bernard et al. 1994a). Based on this definition by the 
AECC, ARDS was characterised as the acute onset of respiratory failure, diffuse bilateral 
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infiltrates on chest radiograph, the absence of elevated left heart filling pressure determined 
either diagnostically with a pulmonary artery catheter (pulmonary artery occlusion pressure 
of < 18 mmHg) or clinically (absence of evidence of left arterial hypertension) (Bernard et al. 
1994b; Fanelli et al. 2013). If the ratio of partial pressure of arterial oxygen to the fraction of 
inspired oxygen (PaO2/FiO2) is less than 300 mmHg, the patient is diagnosed with acute lung 
injury  (ALI), and if the PaO2/FiO2 ratio is less than 200 mmHg, the patient is diagnosed with 
acute respiratory distress syndrome (ARDS) (Bernard et al. 1994b). However, confusion 
arose among clinicians regarding the AECC definition especially on the PF ratio cut off 
values of 300 and 200 mmHg (Costa & Amato 2013; Fanelli et al. 2013). Thus, the definition 
of ARDS has been revised with the aim to improve the current limitations of the AECC 
definition (Kattwinkel et al. 2004) .  
 
In 2012, ARDS was redefined, into what is now known as the Berlin definition. In particular, 
the term of Acute Lung Injury (ALI) has been removed to eliminate confusion (Kattwinkel et 
al. 2004). In the Berlin definition, it recommends to use of three categories of ARDS based 
on degree of hypoxemia; Mild ARDS (200 mmHg < PaO2/FiO2 ≤ 300 mmHg), moderate 
ARDS (100 mmHg < PaO2/FiO2 ≤ 200 mmHg), and severe ARDS (PaO2/FiO2 ≤ 100 mmHg). 
The acute time frame is also specified to be within 1 week. The lower the PaO2/FiO2 ratio, 
the less inspired oxygen getting into the blood, and thus the worse the patient’s condition.  
 
ARDS patients admitted to the intensive care unit (ICU) require mechanical ventilation (MV) 
for breathing support due to the severe arterial hypoxemia and difficulty in breathing 
(Ashbaugh et al. 1967). During the last several decades, ARDS has had a major influence on 
mortality and morbidity in ICU patients worldwide. It was reported that there are 
approximately 200,000 cases per year of ARDS in the USA (Rubenfeld et al. 2005; The 
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Acute Respiratory Distress Syndrome Network 2000) and the hospital mortality rate has been 
reported to be between 30% and 60% (Luhr et al. 1999; Manzano et al. 2005; Phua et al. 
2009; Reynolds et al. 1998; Sigurdsson et al. 2013). However, some studies have suggested 
that these mortality rates have been reduced due to the implementation of new protective 
ventilation strategies (Bernard 2005; Rubenfeld et al. 2005; Sigurdsson et al. 2013). These 
results elucidate the importance of having an optimal ventilator strategy to reduce the 
mortality rate in ARDS patients and equally reduce cost of the ICU stay at the same time.  
 
1.2  Mechanical Ventilation 
 
Since there is no specific treatment for ARDS patients, the only treatment that clinicians can 
offer is providing an environment that can aid and support ARDS patients’ recovery. 
Mechanical ventilation (MV) is currently the most prevalent treatment for ARDS patients in 
Intensive Care Unit (ICU). Although there are a range of clinical therapies suggested for 
ARDS patients, only a few of them have been proven to be clinically effective and only with 
little statistical significance (Ware & Matthay 2000). The idea of MV therapy is to assist 
patient and minimise the work of breathing (WOB) by maximising recruitment and 
oxygenation. MV provides the means of breathing support by partially or fully taking over 
the patients breathing effort. However, if ventilation settings are not properly adjusted, these 
patients are exposed to the risk of further lung injury and complications (Dreyfuss & Saumon 
1998; Slutsky 1999). Hence, setting MV is a delicate balance between too little support and 
the risk of further lung injury due to too much support.  
 
There are two primary, commonly used modes of MV typically used by clinicians. 
Specifically, pressure controlled ventilation (PCV) and volume controlled ventilation (VCV). 
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Under PCV, the Positive End-Expiratory Pressure (PEEP) and Peak Inspiratory Pressure 
(PIP) are set directly by the clinicians, and tidal volume (Vt) is as indirect result under this 
setting. Thus, the volume change during inspiration is a passive process. In contrast, under 
VCV, the PEEP and the Vt are chosen by the clinician. The Vt is set using a fixed flow rate 
since volume is the integral of flow rate with respect to time. The flow rate can be constant or 
varied during inspiration, and the PIP is an indirect result of these settings. Thus, the pressure 
change during inspiration is a passive process, in this latter mode. 
 
1.3  Mechanical Ventilation Parameters  
 
There are thus two main ventilator parameters that are clinically set, which are Positive End-
Expiratory Pressure (PEEP) and Tidal Volume (Vt). 
 
1.3.1  Tidal Volume (Vt) 
 
The tidal volume (Vt) is the volume of air delivered to the lung per breath. If it is too high, it 
will over-distend the lung and cause Ventilation Induced Lung Injury (VILI) (Caironi et al. 
2010; Chiumello et al. 2008; Slutsky 1999). In particular, VILI occurs as a result of excessive 
tidal volumes and is known as volutrauma, where VILI caused by excessive pressure is 
known as barotraumas (Chao & Scheinhorn 1996; Dreyfuss & Saumon 1992). Setting 
optimal tidal volume is important. If it is too low, it will result in an inadequate amount of 
oxygenation and atelectasis, which is damaging to the alveoli. In normal conditions, the goal 
is that Vt provides maximum gas exchange for minimum breathing effort.  Tidal volume 
relates to lung strain over the entire organ, where strain is ratio of tidal volume over 
functional residual capacity (Vt /FRC).  
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For ARDS patients, lung stress and strain may be higher compared to healthier people. Thus, 
large Vt provides higher strain with a higher risk of VILI for ARDS patients. Therefore, a 
study by ARDS network (The Acute Respiratory Distress Syndrome Network 2000) 
recommended using a lower Vt range to provide safe and lung protective strategies for MV 
patients. The study carried out by ARDS Network reported that patients ventilated with lower 
Vt (6ml-8ml/kg) resulted with lower mortality rate in ARDS patient cohort than those given 
12 ml/kg (The Acute Respiratory Distress Syndrome Network 2000). It is thus believed that 
low Vt can reduce VILI by decreasing plateau and peak pressures, and/or by stabilising 
alveoli (DiRocco et al. 2006). While most studies have similar results, there are still many 
debates about the use of low or high Vt for MV (Bruhn et al. 2011; Eichacker et al. 2002). 
 
1.3.2  Positive end expiratory pressure (PEEP) 
 
Positive end-expiratory pressure (PEEP) is applied during MV to prevent de-recruitment at 
the end of expiration by keeping unstable lung units open, and to recruit the new lung units, 
which improve oxygenation (Amato et al. 1998; Meade et al. 2008). PEEP represents the 
pressure at the end of expiration to which the lung is allowed to deflate and is greater than 
atmospheric pressure to hold open damaged lung units. The objective of PEEP is to increase 
the level of oxygenation by increasing the number of recruited alveoli by lifting the lung 
pressure at the end of expiration so that alveoli will remain open, and thus reducing the 
repetitive and damaging process of opening and collapse of these lung units to allow them to 
heal. 
 
Several studies (Briel et al. 2010; Mercat et al. 2008; Schirrmann et al. 2010) noted that with 
adequate PEEP during recruitment manoeuvres, the collapsed alveoli can be recruited to 
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improve oxygenation. However, if high pressure is applied, there are high risks of over-
distension of the already opened and still healthy alveoli. In some studies, it was found that 
compliance was lowest at highest PEEP which shows that overstretching did occur at this 
highest PEEP (Suh et al. 2003). Thus, using the highest PEEP possible is not the best solution 
for optimum ventilation therapy as it may cause more harm than good and contribute to VILI 
(Brower et al. 2004; Sundaresan & Chase 2012).  
 
There is currently no standard method for PEEP selection. Thus, clinicians often resort to 
choosing PEEP based on personal experience, intuition or generalised approach (Levy 2004). 
If too high, it risks injuring healthy lung units, and if PEEP is too low, it results in continuous 
recruitment and de-recruitment of ARDS affected alveoli and further damage. As patient 
condition is variable, these PEEP selection methods may under, or over-support patients, or 
both over time as patient condition evolves dynamically, resulting in suboptimal ventilation, 
further complicating patient condition and outcome (Pavone et al. 2007; Petersen 1983; 
Puybasset et al. 2000; Slutsky 1999; Villar et al. 2006). Thus, the optimal PEEP 
determination by clinicians remains an elusive goal. 
 
1.4  Problem in MV 
 
The major problem in MV therapy is the lack of standardised clinical protocols for adjusting 
MV settings for treating ARDS, as well in general. Currently, ventilator settings and 
protocols are strongly dependent on the experience of the clinicians, resulting in variable 
protocols with limited effectiveness over broad cohorts (Briel et al. 2010; Grasso et al. 2007; 
Hodgson et al. 2011; Meade et al. 2008). As a result, many major, general trials have failed. 
Incorrect ventilator settings can cause further lung injuries, such as barotrauma, volutrauma, 
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atelectasis and biotrauma (Chao & Scheinhorn 1996; Lipes et al. 2012; Tremblay & Slutsky 
1997). Thus, to minimise these negative effects that may negatively affect or significantly 
deteriorate the condition of ARDS patients, different approaches to setting MV need to be 
developed, proven, and implemented.  
 
While MV is the main therapy for ARDS patients, there are major concerns on the 
management of MV, especially around the length of time of using MV. The longer a patient 
remains on ventilator, the higher the chance of complications, including airway injury due to 
the endotracheal tube, as well as increased risk of ventilator-associated pneumonia (VAP). 
Several studies suggested that MV should be applied for the shortest period of time necessary 
to prevent impairment of lung function and other complications (Anzueto et al. 1997; Forel et 
al. 2012). In support, patients on MV have a mortality rate 4 times higher than non-MV 
patients (Dasta et al. 2005), which increases as length of MV increases. In addition, due to the 
length of stay in ICU, daily costs for MV patients were consistently greater compared to non-
MV patients, costing an estimated $1440 USD more per patient per day which is almost 
doubling the daily cost of an ICU patient (Davidson et al. 2014). Hence, the need for better, 
patient-specific protocols is patient-centered, as well as economic.  
 
MV therapy aims to maximise recruitment and oxygenation, while minimising the risk of 
VILI. Thus, the MV setting has to be as minimally invasive as possible by adjusting the 
optimal level of PEEP without compromising these goals. However, while the management 
strategy of ventilator still remains under debate (Amato et al. 1998), it is often difficult to 
achieve the primary goal of improving oxygenation with optimal MV settings, as well as 
ensuring that the lungs heal properly. The difficulty is compounded by the fact that each 
patient has a unique disease state and evolution. 
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One of the emerging methods to achieve the objective of optimal ventilator setting is through 
model-based methods (Sundaresan et al. 2011a; Yuta et al. 2004). Model-based methods are 
capable of providing unique insight to patient-specific condition and response to treatment. 
These methods are relatively non-invasive or non-additionally-invasive, and have shown 
promising outcome in guiding therapy (Chiew et al. 2011; Sundaresan et al. 2010; van 
Drunen et al. 2013). Thus, the motivation of this research is to develop model-based and 
patient-specific lung models that are able to analyse and aid clinicians in choosing the 
optimum MV settings based on patient-specific needs and response. 
 
1.5  Medical Imaging 
 
Medical imaging is an element in assessing the heterogeneity and impact of ARDS. They are 
thus needed to aid model development and validation. 
 
1.5.1  Computed Tomography 
 
Computed tomography (CT) scan has been widely employed to study ARDS patients since it 
allows the clinicians to assess and monitor patient’s lung condition (Gattinoni et al. 2006; Lu 
et al. 2001). For CT scans, Hounsfield units (HU) are used to describe the x-ray attenuation 
which is known as radio density that caused by different tissues. Based on the attenuation of 
individual pixels of the scan, the alveoli can be determined to be either recruited, de-recruited 
or overinflated (Sundaresan & Chase 2012). In particular, the study by Viera et al. (Vieira et 
al. 1998) using CT scans found that the threshold of -900 HU might be used in patients with 
ALI/ARDS at risk of MV induced lung barotrauma due to over-distended lung. Although CT 
scan is a useful tool to detect over-distended alveoli, it exposes the patient to potential risks 
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such as transporting patients out from the ICU and expose to additional radiation dosage 
(Brenner & Hall 2007; Gattinoni et al. 2001; Pesenti et al. 2001; Tubiana et al. 2008). Thus, 
the use of CT scan to guide MV treatment remains limited.  
 
1.5.2 Electrical Impedance Tomography 
 
Electrical Impedance Tomography (EIT) is another medical imaging that potentially suitable 
for bedside lung monitoring. It was first developed for medical monitoring by Barber and 
Brown (Barber & Brown 1984) and used a method by generating a cross-sectional image of 
lungs using the spatial distribution of electrical conductivity (Denai et al. 2010). Despite its 
advantages as a non-invasive bedside tool that can be used for continuous monitoring of MV 
therapy, it has limited spatial resolution, requires complex image reconstruction algorithms, 
and requires skilled operators to implement. It is an emerging, but non-invasive technology.  
 
1.6  Review of Mathematical Respiratory System Models 
 
In the literature, the development of mathematical models has been used with great success to 
delineate the physiology of the mechanical respiratory system. These models range from very 
simple lumped parameter models (Carley & Shannon 1988; Grodins et al. 1967; Trueb et al. 
1971) to highly complex finite element models (Donovan 2011; Tawhai et al. 2011; Tawhai 
et al. 2004). However, to date, most models are developed for educational purposes (Chase et 
al. 2006b; DiCarlo 2008) and only a few have been designed with a real-time, patient-specific 
therapeutic goals or outcomes in mind (Ben-Tal 2006). The following sections review several 
mathematical models that have been developed to provide physiological insight into lung 
conditions that have opened up new idea and knowledge in lung mechanics modelling. 
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1.6.1 Recruitment Model  
 
One of the most important strategies in MV is to recruit lung units to improve oxygenation 
and to also keep the lung open. Animal studies using in vivo microscopy showed that the 
ARDS affected alveoli can be characterised into three different types (Schiller et al. 2003). 
All the three types of alveoli demonstrated different recruitment pattern and compliance. 
Type 1 alveoli are characterised as the most heathy and normal alveoli, as the alveoli do not 
collapse at the end of expiration and do not change volume significantly during tidal 
ventilation. In contrast, Type 2 alveoli are defined as slightly to moderately affect by lung 
injury. Their sizes and shapes change significantly during tidal ventilation, and may collapse 
at the end of expiration. Type 3 alveoli are the most affected by the lung injury where large 
volume changes as pressure increases and collapse at the end of expiration. In addition, 
alveoli that demonstrate repetitive alveolar collapse and expansion (RACE) are larger than 
normal alveoli at peak inspiration. Thus, this specific aspect increases the size of the alveoli 
or over-distension (Schiller et al. 2001).  
 
Traditionally, the lung was assumed to expand by isotropic expansion of alveoli during 
recruitment  (Albaiceta et al. 2007; Hickling 2002). The recruitment of alveoli was 
interpreted using a static or dynamic pressure volume (PV) curve. Based on the PV curve, 
alveolar recruitment is assumed to occur at the lower inflection point (LIP), which was then 
followed by balloon-like expansion of recruited alveoli. The alveoli require an initially high 
pressure to overcome elastic forces before it start to expand and resulting with major volume 
change. Over-inflation of alveoli occurs at the upper inflection point (UIP), which resulting in 
sudden decrease of compliance due to the over-stretching effect. 
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However, this traditional theory does not agree to clinical in-vivo studies that have presented 
different mechanism of lung expansion.  Schiller et al. found (Halter et al. 2003) that normal 
healthy alveoli do not expand as pressure is increased, which contributes to a very little of 
volume changes. Thus, this result shows that balloon-like expansion is not the correct 
mechanism of lung volume change. Once alveoli are recruited, the volume does not change 
significantly for healthy units and some ARDS affected alveoli (Schiller et al. 2003).  
 
In addition, several studies observed that recruitment and de-recruitment occurs continuously 
for the entire breathing cycle especially between LIP and UIP which contribute to the 
hysteresis observed in PV curves (Cheng et al. 1995; Jonson et al. 1999). It is also shows that 
as PEEP increases, volume of the lung can increase for a given pressure which delineate that 
there is an additional recruitment occurs above LIP (Carney et al. 1999; Jonson et al. 1999). 
Thus, recruitment theory is more relevant in understanding the lung mechanics of ARDS 
patients. Figure 1.1 illustrates the different between traditional theory and the recruitment 
theory. 
 
From this recruitment theory, a recruitment mathematical model was developed by Hickling 
(Hickling 1998b). This recruitment model is based on recruitment and de-recruitment using 
threshold opening pressure (TOP) and threshold closing pressure (TCP). The model defined 
the relation between pressure and volume (PV) curve and recruitment status where the PV 
curve changes with recruitment. It has been added into several models to capture patient-
specific parameters that can guide clinicians in selecting the optimal setting of the MV 
(Schranz et al. 2012a; Sundaresan et al. 2009). This model is able to characterise ARDS lung 
physiology based on this concept of recruitment and simplified lung physiology. In particular, 
the lung can be modelled as a collection of alveoli or lung units with discrete layers that 
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subjected to superimposed pressure. The compartment of the bottom experiences higher 
superimposed pressure than the ones above due to the weight of the lung. Superimposed 
pressure is an additional pressure applied to the lung units by the gravitational force of the 
lungs above it. 
 
 
 
Figure 1.1: Alveolar expansion based on traditional and recruitment theory. (Top) Isotropic 
expansion of alveoli as isotropic balloon like based on traditional theory. (Bottom) 
Recruitment theory describes the alveolus is either open or closed. (Chiew 2013) 
 
 
In this recruitment model, the pressure at which alveoli will start to open and inflate is known 
as the Threshold Opening Pressure (TOP), whereas Threshold Closing Pressure (TCP) is 
known as the point when the alveoli start to deflate. Since recruitment and de-recruitment 
Traditional Theory 
Recruitment Theory 
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occur throughout the breathing cycle, the TOP and TCP are widely distributed along 
pressure, rather than the LIP and UIP as traditionally assumed (Crotti et al. 2001; Pelosi et al. 
2001). In this model, quasi-static volume is calculated at each airway pressure increment. 
During inflation, if the applied airway pressure from MV is higher than the TOP, the unit is 
recruited and assumes a lung volume. Each opened unit volume is added to form the inflation 
PV curve. In contrast, if the TCP exceeds the applied airway pressure, the lung unit collapses 
and loses the unit volume, which thus creates the deflation curve. The inflation and deflation 
curves then create the overall lung PV curve.  
 
Although the recruitment model by Hickling is able to capture basic characteristics of lung 
mechanics by simulating the relationship between pressure, volume, and the recruitment 
status of the lung units, this model is unable to predict the volume change resulting from a 
change in PEEP. Thus, with higher PEEP, it may overstretch and damage some healthy 
alveoli. 
 
Similarly, Sundaresan et al. (Sundaresan et al. 2009) developed a minimal model than applied 
the similar recruitment concept. This model accounts for stiffer, smaller volume nature of its 
mechanics as well as the basic mechanism by which the recruitment of lung for gas exchange 
and breathing can be increased. It is able to estimate and provide unique insight to patient-
specific lung condition based on calculation of the mean and standard deviation of the TOP 
and TCP. Despite its capability of monitoring patient-disease state, predicting recruitment for 
changes in PEEP, and to guide MV therapy, the minimal model designed only accounts for 
both two alveoli conditions, either recruited or de-recruited (Sundaresan et al. 2011a; 
Sundaresan et al. 2009). There is no measure of alveolar stress or strain that can lead to 
(local) lung damage due to excessive pressure. Thus, what will happen to the healthy alveoli 
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if the value of PEEP is increased to recruit collapsed alveoli? There is no clinical benefit in 
recruiting ARDS affected alveoli if the PEEP or pressure required damages healthy alveoli in 
less dependent region. Therefore, further insight into estimation of alveoli pressure may 
extend the model potential.  
 
1.6.2 Model-based LIP and UIP 
 
Another well-known method to assess the lung condition is to monitor the alveolar pressure 
using the static PV curve model. This model applies the concept of LIP and UIP in selecting 
appropriate PEEP level for MV setting (Albaiceta et al. 2008). Static PV curves have been 
extensively used in the treatment and management of patients with ARDS in the past 
(Albaiceta et al. 2003; Henzler et al. 2003; Suter et al. 1975; Venegas et al. 1998). It 
resembles a sigmoidal curve with no hysteresis which is unique for each patient. Thus, 
mathematical models such as the Venegas model (Venegas et al. 1998) which describes the 
shape of the sigmoidal curve can be used to identify the static PV curve (Albaiceta et al. 
2007). Based on the static PV curve, clinicians typically set PEEP such that it is between the 
LIP and UIP. However, the LIP and UIP can take on range of values and differ between 
models and between patients, as well as over time. They also do not offer one unique setting 
(Sundaresan & Chase 2012). Hence, selecting optimal PEEP based on the static PV curve is 
limited in clinical application, but offers some useful insights.  
 
1.6.3 Lumped parameter models 
 
Lumped parameter models, such as the single compartment linear lung model (LLM), are less 
computationally intense. These simpler models have shown clinical potential in monitoring 
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patient’s respiratory mechanics in real-time to guide clinical therapy (Avanzolini & Barbini 
1984; Lucangelo et al. 2007). The trade-off being that these simple models are not capable of 
providing high resolution information compared to more complex models. This model is 
extensively used this research because of its identifiability and ease of use, and will be 
discussed in details in Chapter 5. 
 
1.6.4 Finite Elements Models 
 
Finite element models of the respiratory system that have been developed offer significant 
understanding of the underlying physiology and offer detailed resolution of complex systems 
(Burrowes et al. 2005; Tawhai & Bates 2011; Tawhai et al. 2004). In addition, these models 
allow detailed estimation on pulmonary gas flow and realistic simulation of lung behaviour as 
each model can represent a unique geometry for a given patient (Burrowes et al. 2011; 
Kitaoka et al. 2007). However, finite element model is computationally intense and requires 
longer time to run a simulation which limits its capability to be used for bedside monitoring. 
 
1.6.5 Airway Branching Models 
 
Airway branching models (ABM) are able to capture physiologically relevant information. 
The ABM (Horsfield et al. 1971; Weibel 1963b) with the airway dimensions and pathways of 
the airway system have been used to predict respiratory pressure-flow responses (Pedley et al. 
1970). However, while anatomically accurate, these models require a-priori knowledge of the 
lung dimensions and can thus only be based on average lung dimensions in humans, which 
can limit application for patient-specific ARDS patients which have their own individual lung 
dimensions that change with disease state. All of these issues limit application in real-time 
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clinical settings. This model is also studied in this research and is presented in Chapter 3 as it 
offers some patient-specific potential developed in this thesis. 
 
A summary of several other model-based methods is listed in Table 1.1. Most of the models 
described were impractical to identify clinically and thus cannot be used to guide therapy due 
to the limited time, data and resources in ICU.  
 
Table 1.1: List of model-based methods in their respected categories  
 
No. Categories and Functions References 
1. Compartment Models (Bates 2009; Lucangelo et al. 2007; Ma 
& Bates 2010; Schranz et al. 2011) 
2. SLICE Methods (Guttmann et al. 1994; Zhao et al. 
2012a; Zhao et al. 2012b) 
3. Stress Index (Grasso et al. 2007; Ranieri et al. 2000) 
4. Stress Strain Approaches (Chiumello et al. 2008; Mead et al. 
1970; Sundaresan et al. 2011c) 
5. Alveolar and Surface Tension Models (Andreassen et al. 2010; de Ryk et al. 
2007; Kitaoka et al. 2007; Morris et al. 
2001; Reddy et al. 2011; Schirrmann et 
al. 2010) 
6 Spontaneous Breathing Models (Khirani et al. 2010; Schuessler et al. 
1997; Zhao et al. 2006) 
7. Mechanical Lung Models (Chase et al. 2006b; Kuebler et al. 
2007) 
 
1.7  Research Focus 
 
This research focuses on multi-scale respiratory system modelling that can be used to guide 
patient-specific MV therapy. The main objectives of this research are to investigate and 
develop new extended models of lung mechanics for ARDS patients by creating model-based 
measures of the potential impact of changing MV therapy parameters to healthy lung units. 
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These models will require a rapid form of parameter identification to define patient-specific 
model from clinical data, in real time, to be used as a complementary metric in guiding MV. 
From these results, patient-specific therapies can be created and the overall approach 
clinically validated in pilot trials. The thesis consists of 10 chapters as follows: 
 
 Chapter 1: Introduction 
 Chapter 2 presents the dynostatic algorithm (DSA) that allows the estimation of 
alveoli pressure during tidal ventilation.  
 Chapter 3 studies extensively on the airway branching model (ABM) and an extended 
model has been developed which allows the estimation of airway pressure drop at 
each bronchial generation with patient-specific airway dimension, α. Using this 
model, the airway condition of a patient can be characterised and thus, could provide 
clinically useful information to clinicians to guide patient-specific therapy.  
 Chapter 4 introduces the importance of estimation of lung elastance in respiratory 
system and discuss several models that estimate lung elastance. 
 Chapter 5 investigates on relation of expiratory time constant with respiratory system 
elastance in retrospective clinical cohorts.  
  Chapter 6 explores the variability of elastance in the clinical trial. 
 Chapter 7 focuses on negative elastance in spontaneously breathing patient. 
 Chapter 8 presents a reconstruction airway pressure model that able to eliminate the 
variability of elastance in clinical data. 
 Chapter 9 summarises and concludes the outcomes of this thesis. 
 Chapter 10 delivers possible future work for this research. 
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CHAPTER 2 
Dynostatic Monitoring of Clinical Data 
 
2.1 Introduction 
 
Estimation of the alveolar pressure is important during mechanical ventilation (MV) to assess 
and prevent the possibility of the over-distension condition of alveoli due to the excessive 
pressure delivered by the ventilator. One particular concern is that the supporting pressure to 
recruit collapsed lung may be too high, leading to ventilator induced lung injury (VILI) from 
over-distension of healthy alveoli. In particular, barotraumas is caused by excessive pressure 
delivered by the ventilator. Without assessment of alveolar pressure, clinical decision making 
is limited. To date, several studies have shown that maintaining alveolar pressure or plateau 
pressure below 30 cmH2O can protect alveoli from over-distension condition and mitigate the 
risk of VILI (Chiumello et al. 2008; Jaswal et al. 2014; Rouby et al. 2004). However, this 
approach limits the ability to use greater pressure when it may be safe.  
 
The application of such positive end expiratory pressure (PEEP) in ventilator settings has 
been shown to greatly improve oxygenation in ARDS patients (Amato et al. 1998; Halter et 
al. 2003; McCann et al. 2001; The Acute Respiratory Distress Syndrome Network 2000). 
However, higher levels of PEEP risk overstretching alveoli, especially for healthy, well-
aerated alveoli (Ricard et al. 2003). Furthermore, it was found that compliance was the lowest 
at highest PEEP which indicates that overstretching and associated nonlinear mechanics do 
occur at higher PEEP levels (Suh et al. 2003). Thus, using the highest PEEP possible is not 
the best solution for an optimum ventilation therapy as it may cause more harm than good. 
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Thus, it is essential for clinicians to be able to estimate alveolar pressure in MV patients in 
real-time, preferably breath to breath. 
 
2.2 Static Pressure Volume Curve  
 
One of the best methods to assess alveolar pressure is the static pressure volume (PV) curve. 
Static PV curves are also known as static compliance curves, and are sometimes used to 
determine the best treatment or selecting optimal positive end expiratory pressure (PEEP) 
(Caramez et al. 2009; Maggiore et al. 2003; Rouby et al. 2013). Dynamically, the pressure-
volume curves measured during inflation and deflation are different. This behaviour is known 
as hysteresis.  
 
In ARDS patients, the static PV curve can also be considered as recruitment curves (Hickling 
1998a) that describe the mechanical behaviour of the lungs and chest wall during inflation 
and deflation. They are calculated during stable airway conditions where there is no air flow 
within the respiratory airways and all viscoelastic forces are equilibrated resulting in reduced 
hysteresis (Henderson & Sheel 2012). The static PV curve is generally measured by three 
different methods: the super syringe technique, the constant flow method, and the multiple-
occlusion method (Harris 2005; Stenqvist 2003). However, it is static, and thus does not 
necessarily capture the dynamic, higher pressures and their effects. 
 
A static PV curve resembles a sigmoid curve with no hysteresis, and is distinctly unique for 
each patient. The most well-known model by Venegas et al. (Venegas et al. 1998) introduced 
the static PV curve as a sigmoid function that fit the overall static PV curve. It is generally 
characterised by an upper inflection point (UIP) and lower inflection point (LIP), as shown in 
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Figure 2.1. The LIP is defined as the point at which slope of the curves increases as the 
recruitment of alveoli increases rapidly. In contrast, the UIP is the point when alveoli begin to 
overstretch and resulting in a sudden decrease in compliance. However, this is a curve for the 
overall lung behaviour and does not capture the superimposed pressure effects of lung 
dependency or depth, and thus cannot capture the impact on alveoli at specific locales.  
 
 
 
Figure 2.1: Schematic of a static PV curve showing LIP and UIP (Bersten 1998) 
 
The LIP and UIP points provides guideline for clinicians to set PEEP (Albaiceta et al. 2008). 
It is suggested that PEEP should be set above LIP to avoid repetitive collapse of alveoli, and 
below UIP to prevent over-distension condition of alveoli (Brower et al. 2004; Ferguson et al. 
2005; Jonson et al. 1999; Mercat et al. 2008; Ward et al. 2002). However, this approach still 
offers a large range of potential values, where a single optimal and patient-specific PEEP 
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value cannot be determined (Sundaresan & Chase 2012). This outcome is a result of still 
leaving a subjective choice to the clinician.   
 
In addition, the location of the LIP and UIP are typically not identifiable during normal tidal 
ventilation (Lichtwarck-Aschoff et al. 2000). More importantly, the methods required to 
obtain the static PV curves are invasive (Lu & Rouby 2000; Servillo et al. 1997), time 
consuming, and cause interruption to MV therapy (Harris 2005; Kárason et al. 2001). These 
issues limit PEEP selection based on static PV loop in normal clinical situations, and it thus 
not practical to use in mitigating over-distension of healthy alveoli. As a result, Karason et al. 
(Karason et al. 2000) introduced the dynostatic algorithm (DSA) which is the most well-
known method to estimate this dyno-static alveoli pressure by producing the dynostatic curve 
during normal breathing condition (Karason et al. 2000; Sondergaard et al. 2003b). 
 
The DSA is a model-based method that can estimate a surrogate of alveoli pressure without 
the need of extensive protocol. In the DSA, the estimated alveoli pressure is based on the 
assumption that airway resistance is always the same during inspiration and expiration at 
isovolume, but not throughout inspiration or expiration (Stenqvist 2003). This assumption 
thus assumes the airway resistance is influenced by the airway geometry and at each airway 
location, the resistance at that point is the same. With this assumption, a surrogate of the 
alveolar pressure, dubbed as the dynostatic pressure, can be estimated during tidal ventilation. 
Thus, this dynostatic pressure at isovolume curve can be used as an alternative for the static 
PV curve.  
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In this chapter, two patients’ cohorts with different airway pressure and flow profile were 
studied using the DSA. These two cohorts will provide a better understanding of the 
algorithm, its performance, and potential for clinical application, and limitations.  
 
2.3 Methodology 
2.3.1 Dynostatic Algorithm Model (DSA) 
 
Proposed by Karason et al. (Karason et al. 2000), the DSA assumes the airway resistance 
during inspiration and expiration are the same at isovolume (Rinsp = Rexp). It thus assumes that 
the airway resistance is a physiological constant, depending on the location of where it is 
measured and that it is not flow dependent, which is a significant simplification. Figure 2.2 
shows an example of the quasi static pressure estimated using the DSA in relation to a 
dynamic pressure volume data during tidal ventilation.  
 
 
 
Figure 2.2: The DSA diagram and resulting quasi-static, single line pressure volume curve 
within the tidal ventilation. 
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Based on these assumptions, a surrogate of the alveolar pressure, known as dynostatic 
pressure (Pdyn), can be derived:  
𝑅𝑖𝑛𝑠𝑝 =  
𝑃𝑖𝑛𝑠𝑝 − 𝑃𝑑𝑦𝑛
𝑄𝑖𝑛𝑠𝑝
= 𝑅𝑒𝑥𝑝 =
𝑃𝑒𝑥𝑝 − 𝑃𝑑𝑦𝑛 
𝑄𝑒𝑥𝑝
 
(2.1) 
𝑃𝑑𝑦𝑛 =
𝑃𝑖𝑛𝑠𝑝 × 𝑄𝑒𝑥𝑝 −  𝑃𝑒𝑥𝑝 × 𝑄𝑖𝑛𝑠𝑝 
𝑄𝑒𝑥𝑝 − 𝑄𝑖𝑛𝑠𝑝
 
(2.2) 
 
where,  𝑄𝑒𝑥𝑝 is the expiration flow, 𝑄𝑖𝑛𝑠𝑝 is the inspiration flow, 𝑃𝑖𝑛𝑠𝑝 is the pressure during 
inspiration, and  𝑃𝑒𝑥𝑝 is the pressure during expiration.  
 
2.3.2 Patient data 
 
A preliminary model validation was performed using datasets obtained from two 
retrospective ARDS cohorts consisting of 10 patient datasets from Sundaresan et al. 
(Sundaresan et al. 2011a) and 10 patient datasets from Bersten et al. (Bersten 1998) (Cohorts 
1 and 2, respectively). Patients in Cohort 1 underwent a modified protocol-based recruitment 
manoeuvre, where these patients were ventilated with several different PEEP levels using a 
ramp flow profile (Sundaresan et al. 2011a). These patients were fully sedated and ventilated 
using Puritan Bennett PB840 ventilators (Covedin, Boulder, CO, USA) with volume control 
(tidal volume = 6-8 mL/kg), synchronized intermittent mandatory ventilation (SIMV) mode, 
throughout the trial.  
 
The airway pressure and flow profile where obtained using a pneumotachometer with a data 
acquisition module connected to the patient’s ventilation circuit Y-piece, sampling at 100Hz. 
Inspiratory volume was obtained through flow integration and drift correction. The end of 
expiratory lung volume (EELV) at each PEEP level was calculated through continuous 
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monitoring of the airway flow at every PEEP changes (Chiew et al. 2011). An example of 
airway pressure, flow rate and volume data from patient S1 is shown in Figure 2.3. The 
demographics and cause of ARDS for patients in Cohort 1 is presented in Table 2.1. 
 
 
Figure 2.3: Example of the Airway pressure data (Top), flow rate data (Middle) and volume 
data (Bottom) for Patient S1 in Cohort 1. 
 
Table 2.1:  Characteristics of the patients in Cohort 1 (Sundaresan et al. 2011a) 
 
Patient  Sex 
Age 
[years] 
Clinical Diagnostic 
S1 Female 61 Peritonitis, COPD 
S2 Male 22 Trauma 
S3 Male 55 Aspiration 
S4 Male 88 Pneumonia, COPD 
S5 Male 59 Pneumonia, COPD 
S6 Male 69 Trauma 
S7 Male 56 Legionnaires 
S8 Female 45 Aspiration 
S9 Male 37 H1N1,COPD 
S10 Male 56 Legionnaires, COPD 
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Patients in Cohort 2 were fully sedated and ventilated using Puritan Bennett 7200ae 
ventilators (Carlsbad, CA, USA) under volume control mode (tidal volume, Vt  = 8-10 
mL/kg) and a square-wave inspiratory flow. Airway pressure data was acquired using a 
(water manometer) strain gauge transducer (Bell and Howell 4-327-I; Trans America 
Delaval, Pasadena, CA, USA). Volumetric flow rate data was acquired using a heated, 
Fleisch-type pneumotachograph (HP-47034A, Hewlett-Packard, Palo Alto, CA, USA) 
(Bersten 1998). Trials were initially performed at baseline PEEP. Trials were then repeated at 
30 min intervals following random PEEP changes between 5 and 15 cmH2O. The final 60 s 
of data from each PEEP level was recorded. The end of expiratory lung volume 
corresponding to each PEEP level was also calculated. Each dataset included recordings of at 
least 3 different PEEP levels, as well as deflation to functional residual capacity (FRC) at 
PEEP = 0 cmH2O. The demographics and cause of ARDS for each patient in Cohort 2 are 
presented in Table 2.2. Figure 2.4 shows an example of airway pressure data, flow rate data, 
and volume data, for patient B10.  
 
Table 2.2:  Characteristics of the patients in Cohort 2 (Bersten 1998) 
 
Patient  Sex 
Age 
[years] 
Clinical Diagnostic 
B1 Male 74 Ruptured abdominal aortic aneurysm 
B2 Male 24 Lung contusion 
B3 Female 72 Legionnaire’s disease 
B4 Male 48 Pancreatitis 
B5 Female 68 Pulmonary embolus 
B6 Male 54 Aspiration 
B7 Male 73 Aspiration 
B8 Male 72 Pneumonia 
B9 Male 81 Aspiration 
B10 Male 47 Liver transplant 
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Figure 2.4: Example of Cohort 2 data from patient B10 for eight breathing cycles. Top: 
Airway pressure data. Middle: Flow rate data. Bottom: Volume data 
 
2.3.3  Data Analysis 
 
For each patient in this study, Pdyn was calculated for every breathing cycle at every PEEP 
using Equation 2.2. The median [Interquartile range (IQR)] of each tidal ventilation Pdyn were 
calculated for comparison. The corresponding maximum Pdyn at each PEEP is also calculated 
as a surrogate of maximum alveolar pressure during tidal ventilation.  
 
2.4 Results 
 
The pressure volume (PV) curves with alveoli pressure determined by the DSA for the two 
cohorts are presented in Figures 2.5 and 2.6. Pdyn results for Cohort 1 and Cohort 2 at each 
PEEP level are also tabulated in Tables 2.3 and 2.4, respectively. 
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Table 2.3:  Patient-specific dynostatic pressure (Pdyn) for Cohort 1 at each PEEP level 
 
Patient 
 𝑷𝒅𝒚𝒏 (cmH2O) 
PEEP 5 PEEP 10 PEEP 15 
 
S1 
 
Median 
[IQR] 
Maximum 
7.87  
[6.67-13.99]  
17.43 
12.61 
[11.24-17.73] 
20.72 
16.97 
[15.97-21.77] 
25.92 
 
S2 
 
Median 
[IQR] 
Maximum 
12.29 
[6.65-14.39] 
15.80 
14.71 
[12.87-18.22] 
20.86 
19.42 
[16.93-23.54] 
26.47 
 
S3 
 
Median 
[IQR] 
Maximum 
7.76 
[5.50-10.96] 
13.66 
12.61 
[10.66-16.35] 
18.66 
15.94 
[14.87-21.13] 
24.45 
 
S4 
 
Median 
[IQR] 
Maximum 
9.43 
[8.17-11.60] 
17.69 
13.30 
[11.81-15.34] 
19.23 
18.82 
[16.39-21.07] 
22.98 
 
S5 
 
Median 
[IQR] 
Maximum 
8.22 
[6.17-15.18] 
28.69 
13.25 
[10.91-17.31] 
28.06 
16.05 
[15.17-21.79] 
29.87 
 
S6 
 
Median 
[IQR] 
Maximum 
8.36 
[6.22-12.96] 
14.99 
13.61 
[10.96-17.20] 
19.49 
16.93 
[15.13-22.19] 
25.13 
 
S7 
 
Median 
[IQR] 
Maximum 
8.82 
[6.54-11.83] 
19.58 
15.23 
[11.59-21.59] 
28.87 
16.62 
[16.21-21.07] 
40.39 
 
S8 
 
Median 
[IQR] 
Maximum 
9.53 
[6.79-12.94] 
16.57 
13.38 
[10.95-17.38] 
20.43 
15.93 
[14.93-20.38] 
25.16 
 
S9 
 
Median 
[IQR] 
Maximum 
8.80 
[6.77-13.29] 
21.12 
13.33 
[10.76-16.92] 
22.38 
17.27 
[15.17-20.91] 
26.79 
 
S10 
 
Median 
[IQR] 
Maximum 
7.72 
[6.18-12.10] 
21.96 
17.06 
[12.23-21.40] 
25.98 
21.20 
[17.63-26.58] 
30.35 
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Figure 2.5: The PV curves and Pdyn trends from Cohort 1 at all PEEP levels for Top Left: 
Patient S1. Top Right: Patient S2. Bottom Left: Patient S3 and Bottom Right: Patient S8.  
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Table 2.4:  Patient-specific dynostatic pressure (Pdyn) for Cohort 2 at each PEEP level 
 
Patient 
 𝑷𝒅𝒚𝒏 (cmH2O), Median [IQR] and Maximum 
PEEP 5 PEEP 7 PEEP 10 PEEP 12 PEEP 15 
B1 
Median 
[IQR] 
Maximum 
5.73 
[4.99-11.40] 
23.92 
8.47 
[7.61-11.29] 
28.03 
- 
12.49 
[11.95-15.22] 
38.63 
- 
B2 
Median 
[IQR] 
Maximum 
4.96 
[4.73-6.79] 
16.89 
- 
10.28 
[9.49-12.00] 
19.27 
- - 
B3 
Median 
[IQR] 
Maximum 
5.89 
[5.14-10.86] 
28.99 
8.12 
[7.42-11.35] 
31.87 
10.27 
[9.79-13.45] 
32.09 
- - 
B4 
Median 
[IQR] 
Maximum 
6.01 
[5.59-8.76] 
23.14 
10.00 
[9.57-13.14] 
25.82 
10.90 
[10.21-13.68] 
24.16 
- - 
B5 
Median 
[IQR] 
Maximum 
5.91 
[4.47-18.14] 
23.32 
12.87 
[6.90-21.99] 
25.43 
19.56 
[9.64-23.22] 
26.36 
20.47 
[15.72-23.82] 
28.35 
- 
B6 
Median 
[IQR] 
Maximum 
4.30 
[4.12-4.86] 
26.01 
6.77 
[6.47-7.65] 
28.53 
9.13 
[8.94-10.15] 
26.44 
11.16 
[11.02-11.58] 
26.75 
- 
B7 
Median 
[IQR] 
Maximum 
5.99 
[5.06-8.22] 
16.14 
8.71 
[7.42-12.30] 
19.59 
11.01 
[10.07-13.98] 
22.46 
13.43 
[12.51-15.56] 
27.67 
- 
B8 
Median 
[IQR] 
Maximum 
6.14 
[5.35-9.92] 
19.34 
9.20 
[7.80-13.59] 
20.60 
- 
14.02 
[12.88-16.86] 
27.88 
- 
B9 
Median 
[IQR] 
Maximum 
- - 
11.42 
[9.86-17.02] 
31.50 
17.54 
[15.04-22.95] 
36.49 
18.86 
[16.97-22.46] 
44.18 
B10 
Median 
[IQR] 
Maximum 
5.74 
[5.00-11.24] 
23.92 
    8.47 
[7.61-11.29] 
28.03 
11.04 
[10.11-14.41] 
37.19 
12.48 
[11.95-15.22] 
38.63 
- 
B11 
Median 
[IQR] 
Maximum 
4.70 
[4.41-5.72] 
16.17 
6.84 
[6.55-7.63] 
21.67 
9.02 
[8.86-10.68] 
24.57 
- - 
B12 
Median 
[IQR] 
Maximum 
6.13 
[4.79-14.37] 
26.51 
- 
11.21 
[9.57-18.01] 
30.30 
- 
16.93 
[14.17-21.78] 
34.23 
30 
 
 
 
Figure 2.6: The PV curves and Pdyn trends from Cohort 2 at all PEEP levels for Top Left: 
Patient B1. Top Right: Patient B3. Bottom Left: Patient B3 and Bottom Right: Patient B12. 
 
 
0 10 20 30 40 50
0
0.5
1
1.5
2
 Pressure, cmH20
 V
o
lu
m
e
,L
 
 
0 10 20 30 40 50
 Pressure, cmH20
 
 
PEEP 5 cmH
2
O
PEEP 7 cmH
2
O
PEEP 12 cmH
2
O
P
dyn
 at PEEP 5 cmH
2
O
P
dyn
 at PEEP 7 cmH
2
O
P
dyn
 at PEEP 12 cmH
2
O
PEEP 5 cmH
2
O
PEEP 7 cmH
2
O
PEEP 10 cmH
2
O
P
dyn
 at PEEP 5 cmH
2
O
P
dyn
 at PEEP 10 cmH
2
O
P
dyn
 at PEEP 12 cmH
2
O
0 10 20 30 40 50
0
0.5
1
1.5
2
 Pressure, cmH
2
O
 V
o
lu
m
e
,L
 
 
0 10 20 30 40 50
 Pressure, cmH
2
O
 
 
PEEP 5 cmH
2
O
PEEP 10 cmH
2
O
PEEP 15 cmH
2
O
P
dyn
 at PEEP 5 cmH
2
O
P
dyn
 at PEEP 10 cmH
2
O
P
dyn
 at PEEP 15 cmH
2
O
PEEP 5 cmH
2
O
PEEP 7 cmH
2
O
PEEP 10 cmH
2
O
P
dyn
 at PEEP 5 cmH
2
O
P
dyn
 at PEEP 7 cmH
2
O
P
dyn
 at PEEP 5 cmH
2
O
31 
 
2.5 Discussion 
 
The DSA model is capable of on-line monitoring of Pdyn without added invasive respiratory 
manoeuvre. This information is important, especially for assessing patient-specific ARDS 
lung condition and their response to MV settings. These disease states and responses to 
therapy are patient-specific, and can be highly variable over time as condition evolves. Thus, 
it is imperative to have real-time assessment. 
 
For safety, some studies have suggested that during tidal ventilation, the alveolar pressure or 
plateau airway pressure should be maintained below 30 cmH2O to prevent barotrauma 
(Chiumello et al. 2008; Jaswal et al. 2014; Rouby et al. 2004). Table 2.3 shows that for most 
patients included in Cohort 1, the maximum estimated Pdyn does not exceed 30 cmH2O, 
except for Patients S7 and S10 at PEEP of 15 cmH2O. These results show that Patients S1-S6, 
S8 and S9 may be safely ventilated at PEEP = 15 cmH2O However, Patients S7 and S10 
should be ventilated at a lower PEEP value of 10 cmH2O to avoid the potential pressure 
induced injury (Chiumello et al. 2008). 
 
In contrast to Cohort 1, it was found that the patients in Cohort 2 experienced higher overall 
Pdyn when PEEP is set above 7 cmH2O. Four of 10 patients had peak Pdyn over 30 cmH2O 
when PEEP is 7 cmH2O. Of note, the ventilation tidal volume in Cohort 2 was set at 8-10 
ml/Kg, which is ~25% higher than the tidal volume settings in Cohort 1. This higher tidal 
volume setting contributed to higher peak Pdyn at lower PEEP settings. Thus, a possible 
hypothesis is that patients can be ventilated with lower tidal volume with increased frequency 
to maintain adequate minute ventilation, which has also been reported (Imai et al. 2001; 
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Meade et al. 2008). However, these results also indicate the trade-off between tidal volume 
and pressure, and flow pattern that make this problem more complex than a simple limit.  
It can be seen in Figures 2.5 and 2.6 that Pdyn increases with PEEP and follows a sigmoidal 
curve that is similar to the static compliance curve (Venegas et al. 1998). Pdyn is a surrogate 
of the alveolar pressure. Thus, Pdyn trends in this study should follow the characteristics of a 
standard static compliance curve, as expected. In addition, combining Pdyn at different PEEP 
levels, the location of LIP and UIP can potentially be identified, which may be useful for 
optimal PEEP selection (Albaiceta et al. 2008). Hence, this approach could enable more 
quantified PEEP selection. 
 
While the static compliance curve characteristics were apparent in both Cohorts 1 and 2, 
there are differences in Pdyn trends between Cohort 1 and Cohort 2, as shown in Figures 2.4 
and 2.5. For Cohort 1, three Pdyn curves at different PEEP can be connected and form one 
sigmoidal curve similar to a static compliance curve as described by Venegas et al. (Venegas 
et al. 1998). Comparatively, Cohort 2 exhibit different characteristics where all three Pdyn 
curves can form 3 independent sigmoidal curves. It can be seen that the Pdyn trend shifted to 
the left when the patient is ventilated at higher PEEP. This shift observed in Cohort 2 also 
implies that patients respiratory system compliance increases with PEEP, and this observation 
can be translated into PEEP induced time-dependent alveoli recruitment (Bates & Irvin 
2002). However, this trend is not always observed, suggesting patient specificity of response 
to MV.  
 
Sundaresan et al. (Sundaresan et al. 2011a), Chiew  et al. (Chiew et al. 2011), Crotti et al. 
(Crotti et al. 2001), and Pelosi et al. (Pelosi et al. 2001) have showed similar trends, noting 
that the ventilation pressure has reached above alveoli threshold opening pressure, leading to 
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recruitment. This recruitment then leads towards reducing the overall threshold opening 
pressure for recruited lung units, increasing compliance. Equally, there is also a protocol 
difference between Cohorts 1 and 2 for the duration of each PEEP level is maintained. In 
Cohort 1, each PEEP level is only maintained for 10 to 15 breathing cycles, compared to 
Cohort 2 where every PEEP level is maintained for 30 minutes. Thus, in Cohort 1, there may 
not be sufficient time for time dependent recruitment (Bates & Irvin 2002), whereas Cohort 2 
allows time-dependent recruitment and has more than sufficient time for stabilisation, which 
in turn changes the observed underlying respiratory mechanics. 
 
The DSA has shown the potential to provide useful information in guiding mechanical 
ventilation. However, it is not without flaws. One of the main limitation of the DSA is that 
the assumption of equal resistance during inspiration and expiration at isovolume may not be 
entirely valid in some or many cases leading to incorrect decisions (Mols et al. 2001). 
Poiseuille equation shows that airway resistance is also dependent on the flow profile 
(Damanhuri et al. 2012), and it is clear that the inspiration flow profiles are different to 
expiration in both Cohorts 1 and 2. Thus, one would not expect this assumption to hold, and it 
may be very poor depending on the flow profile used on inspiration.  
 
Furthermore, the DSA cannot be applied for all ventilator modes, as stated in (Sondergaard et 
al. 2003a). Next, the DSA can only provide information on the overall lung condition, which 
is not specific, as the lung consists of many branches and lung units, each with their own 
structure, shape, and interaction with pressure and flow. Thus, a more patient-specific model 
is required that could give more information on the lung at the specific branches that include 
the airway resistance and alveolar pressure information.  
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2.6 Summary 
 
The DSA is the first on-line monitoring method proposed in calculating alveolar pressure for 
ARDS or MV patients. It has potential to guide clinicians in selecting the best PEEP based on 
the measurement of the alveolar pressure without additional invasive equipment or protocols 
needed. However, the ability of this method to guide therapy is limited because it does not 
provide or include information about airway resistance. It thus cannot offer further insight 
into patient-specific condition (Kárason et al. 2001; Mols et al. 2006). In Chapter 3, a patient-
specific airway branching model (ABMps) is presented. Prior airway branching models 
(ABM) have not been patient-specific or applied in real-time. This model seeks to bridge this 
gap and combine the DSA and ABM models to estimate the pressure drop due to airway 
resistance in detail. The model will provide unique insight and understanding into the topic 
on the airway resistance during mechanical ventilation. 
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CHAPTER 3 
Airway Branching Model 
 
3.1 Introduction 
 
One widely used model that is able to capture physiologically relevant information of lung 
morphology is the airway branching model (ABM) (Horsfield et al. 1971; Weibel 1963a). 
The ABM using known airway dimensions and pathways of the airway system has been used 
to predict respiratory pressure-flow responses (Pedley et al. 1970). The ABM models the 
human lung as a bifurcating tree with 23 generations physiologically and the alveoli are 
present in all generations beyond approximately generation 17 where gas exchange occurs 
(Soong et al. 1979). It is an idealized model of observed anatomy to which fundamental fluid 
mechanics can be applied. 
 
In the ABM, a pressure drop occurs after each branch is due to the resistive components of 
the airway wall and the head loss (Burrowes et al. 2005; Katz 2012). By estimating the 
pressure drop for each of these airway branches, the alveoli pressures can be estimated for a 
given ABM structure and model input. This outcome provides the opportunity to monitor 
‘regional’ specific alveoli pressures that could be used to understand healthy and damaged 
alveoli pressure, and thus potentially to prevent over-distension of the lung that could lead to 
lung injury.  
 
In practice, the ABM has been used to estimate respiratory pressure-flow responses in non-
critically ill subjects (Horsfield et al. 1971; Katz et al. 2011; Pedley et al. 1970; Weibel 
1963a). However, ABM models are very general. They use a set of global airway dimensions 
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that do not reflect patient-specific conditions and have not been validated in critically ill 
patients with respiratory failure. These issues limit bedside application of this model in 
monitoring or titrating mechanical ventilation. 
 
As mentioned in Chapter 2, the dynostatic algorithm (DSA) is currently the most well-known 
method to estimate alveoli pressure by producing the dynostatic curve during typical, 
dynamic breathing conditions (Karason et al. 2000; Sondergaard et al. 2003b). However, the 
ability of this method to guide therapy is limited because it does not provide or include 
information about airway resistance. It thus cannot offer further insight into patient-specific 
or alveoli-specific condition (Karason et al. 2001; Mols et al. 2006). Therefore, the proposed 
patient-specific airway branching model (ABMps) seeks to bridge this gap and merge the 
DSA and ABM models to estimate the pressure drop using the physiological dimensions of 
human airways. 
 
In particular, this study develops the ABMps to capture patient-specific airway pressure 
changes and unique patient-specific clinical information that is not available from the general 
ABM or DSA. Three models are presented: 1) the general ABM; 2) the dynostatic algorithm; 
and 3) the patient-specific ABMps. These models seek to add the patient and/or condition 
specificity that the DSA lacks, while retaining the ability to capture alveolar pressures. It thus 
introduces a mixture of novel elements to the overall modelling approach.  
 
The models are compared in a retrospective analysis using clinical data from critically ill 
mechanical ventilation patients to validate the overall approach. Weibel’s well-known model 
(Weibel 1963a) includes alveolar volume. However, this work is seeks to capture alveolar 
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pressures and thus does not include alveolar volume, which is a difference in the two 
analyses. This work has been published as a journal article (Damanhuri et al. 2014).  
 
3.2 Methodology 
3.2.1 General Airway Branching Model 
 
The general ABM is a symmetrical branching tree with physiological airway branching 
dimensions (Damanhuri et al. 2012). Most of the general ABMs assume that the airway 
generations go up to 23 generations (Katz 2012; Pedley et al. 1970). In this study, the general 
ABM models the trachea as generation 0 and the alveoli are located at generations 17-23. 
Figure 3.1 shows the schematic ABM structure and the physical dimensions at every branch 
generation are shown in Table 2 (Pedley et al. 1970). It is assumed that the airway 
dimensions are kept constant during inspiration.   
 
 
 
 
 
 
Figure 3.1: The airway tree structure in which airways are specified by generation number, 
beginning with trachea (Bates 2009) 
 
This modelling approach captures head loss as part of Poiseuille model used. Poiseuille flow is 
defined (Bates 2009; West 2012) :  
Generation 0 
Generation 1 
Generation 2 
Generation 3 
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∆𝑃𝑛 =
128𝜇𝐿𝑄
𝜋𝐷4
 
 (3.1) 
 
where μ, is the dynamic viscosity of air (1.9x10-5 Pa·s /1.9x 10-7cmH2O·s), L is the length of 
the particular airway branch, D is the diameter of the particular airway branch and Q is the 
flow rate of airway branch. 
 
Table 3.1: Physical measurements of bronchial paths (Pedley et al. 1970). 
 
Branch Generations 
Diameter 
(mm) 
Length  
(mm) 
Reynolds 
number 
-1 (ETT) 
 
9 
 
330 
 
390 
 
0 (Tracheal) 
 
18 120 775 
1 
 
12.20 48 573 
2 
 
8.30 19 427 
3 
 
5.60 8 307 
4 
 
4.50 13 198 
5 -16 
 
3.50 – 0.60 10.70 – 1.70 123 – 0.60 
17 – 22 
 
0.57 – 0.43 1.50 – 0.63 0.56 – 0.41 
23 
 
0.40 0.50 0.02 
 
Head loss is defined as a pressure drop along the branching system that consists of major and 
minor losses (Katz et al. 2011).  The major loss is defined as the pressure drop in the straight 
sections of the airway branching system (Katz et al. 2011) : 
∆𝑃𝑚𝑎𝑗𝑜𝑟 = 𝑓
𝐿𝑉2
2𝐷
 
 (3.2) 
 
The model thus assumes that laminar flow exists in the branches since the diameter for all 
branches is less than 30 mm with Reynolds  number less than 2000 (Burrowes et al. 2005; 
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Horsfield & Woldenberg 1989; Katz 2012). Thus, the laminar flow friction factor (f) is 
defined: 
𝑓 =  
64
𝑅𝑒
 
 
(3.3) 
where Re is the Reynolds number based on the branch diameter: 
𝑅𝑒 =  
𝜌𝑉𝐷
𝜇
 
 (3.4) 
 
where 𝑉 is the velocity of the flow of the airway branch. The velocity of the flow can be 
defined in terms of flow rate: 
𝑉 =  
4𝑄
𝜋𝐷2
 
 (3.5) 
 
Hence, substituting Equations 3.3, 3.4 and 3.5 into Equation 3.2, the major head loss can be 
derived: 
𝑃𝑚𝑎𝑗𝑜𝑟 =
128𝜇𝐿𝑄
𝜋𝐷4
 
 (3.6) 
 
Equations 3.1 and 3.6 show that pressure drop due to Poiseuille flow and the major loss are the 
same, as expected. 
 
In this specific model, estimates from (Damanhuri et al. 2012) incorporate minor loss 
information due to the bifurcation of each branch starting from generation 1, as shown in 
Figure 3.2. Every time the branch bifurcates to the next generation, there is a change in the 
velocity distribution. Thus, this airway resistance and minor loss will contribute to the 
pressure drop over the bronchial paths. 
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Figure 3.2: The Poiseuille pressure drop, 𝛥𝑃n, and minor loss pressure drop, ΔPminor at each 
of the branching respiratory system for ABMps. 
 
In addition to the resistance component of the bronchial part, there is an additional resistance 
in the endotracheal tube (ETT). All of the patients in this study had ETT with the same 
dimensions. The length of the ETT was 330 mm and the diameter was 9 mm (Straus et al. 
1998; Sundaresan 2010). The resistance induced by the ETT is added to the overall model 
results. In all cases, the ETT dimensions can be assumed to be known with no loss of 
generality.  
 
The ETT is at generation -1, the trachea at generation 0, and then continuing to the remaining 
generations up to generation 23. With the added ETT in the ABM model, the total pressure 
drop due to the resistance component, minor loss and the artificial conducting airway can be 
modelled: 
∆𝑃𝐴𝐵𝑀 = ∆𝑃𝑛 + ∆𝑃𝑚𝑖𝑛𝑜𝑟 (3.7) 
 
where  
∆𝑃𝑛 =
128𝜇
𝜋
∑
𝐿𝑛𝑄𝑛
2𝑛𝐷𝑛  4
23
𝑛=−1
 
(3.8) 
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∆𝑃𝑚𝑖𝑛𝑜𝑟 =
8𝐾𝐿𝜌
𝜋2
∑
𝑄𝑛
2
𝐷𝑛  4
23
𝑛=−1
 
(3.9) 
 
where KL is the minor loss coefficient (= 2) (Munson et al. 1990), ρ is the density (1.25 
kg/m
3
), n represents the airway branch generation, Ln is the length of the particular airway 
branch, and Dn is the diameter of the particular airway branch. The flow rate of airway branch 
(Qn) is assumed to be half of the previous generation flow rate based on an even split between 
the two branches. 
 
This combined model is unique for this clinical application (Damanhuri et al. 2012). 
However, it is entirely general based on the data in Table 3.1 and fixed structure.  
 
3.2.2 Dynostatic Algorithm Model (DSA) 
 
In this study, another method of pressure drop estimation is performed by using the 
dynostatic algorithm (Sondergaard et al. 2003a; Sondergaard et al. 2003b). This dynostatic 
model as proposed by Karason et al. (Karason et al. 2000) has been explained in detail in 
Chapter 2. Thus, the pressure drop (∆𝑃𝐷𝑆𝐴) during inspiration is estimated: 
∆𝑃𝐷𝑆𝐴   =  𝑃𝑖𝑛𝑠𝑝 −  𝑃𝑑𝑦𝑛 (3.10) 
 
where 𝑃𝑖𝑛𝑠𝑝 is the pressure during inspiration and Pdyn is the dynostatic pressure. 
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3.2.3 Patient-Specific Airway branching model (ABMps) 
 
This general ABM presented is extended to account for patient-specific physiological 
conditions observed in measured pressure and volume data. The ABMps airway pressure 
drop is defined:  
∆𝑃𝐴𝐵𝑀𝑃𝑆 = ∆𝑃𝑛𝑃𝑆 + ∆𝑃𝑚𝑖𝑛𝑜𝑟𝑃𝑆 (3.11) 
 
A patient-specific multiplier (α) can be used to uniformly alter the bronchial diameter defined 
in Table 2 to better match the observed data. Incorporating this factor into Equations 3.8 and 
3.9, yields Equations 3.12 and 3.13, respectively. 
∆𝑃𝑛𝑃𝑆 =
128𝜇
𝜋
∑
𝐿𝑛𝑄𝑛
2𝑛𝛼4𝐷𝑛  4
24
𝑛=0
 
(3.12) 
 
∆𝑃𝑚𝑖𝑛𝑜𝑟𝑃𝑆 =
8𝐾𝐿𝜌
𝜋2
∑
𝑄𝑛
2
𝛼4𝐷𝑛  4
24
𝑛=0
 
(3.13) 
 
where α is defined as patient-specific relative of airway diameter and is limited to α = [0.45, 
1.50]. If α = 1.0, the patient will follow the general airway dimensions proposed by 
(Horsfield et al. 1971). If α is < 1.0, the patient-specific airway is relatively smaller than the 
Horsfield model (Horsfield et al. 1971), perhaps indicating that airway constriction. Finally, 
if α >1.0, the patient has an effectively larger airway. Larger and smaller airways in this 
context imply differences in resistance in the observed data. Hence, they may also capture 
relative over-distension with pressure, as well as patient-specific state. 
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To estimate a patient-specific α, ∆𝑃𝐴𝐵𝑀𝑃𝑆 is assumed to be the same as ∆𝑃𝐷𝑆𝐴, where ∆𝑃𝐷𝑆𝐴 
is the most currently well-accepted method to estimate alveoli pressures. Hence, substituting 
Equations 3.12 and 3.13 into Equation 3.11, a patient-specific α can be derived: 
𝛼 = √
128𝜇
𝜋∆𝑃𝐷𝑆𝐴 
∑
𝐿𝑛𝑄𝑛
2𝑛𝐷𝑛  4
24
𝑛=0
+  
8𝐾𝐿𝜌
𝜋2∆𝑃𝐷𝑆𝐴 
∑
𝑄𝑛
2
𝐷𝑛  4
24
𝑛=0
4
 
(3.14) 
 
Patient-specific α values are identified through a minimal difference algorithm. Figure 3.3 
shows the flow chart in determining patient-specific α.  
  
 
 
 
 
 
 
 
 
Figure 3.3: A flowchart on selecting the optimal α for each patient in ABMps model. 
 
The value for α for each patient and PEEP value was calculated using measurements 
of ∆𝑃𝐷𝑆𝐴, and 𝑄𝑛 and values of Ln, and Dn, from Table 2 in Equation 3.13. Thus, a different α 
value is obtained for each PEEP level and for each patient. The area under the curve (AUC) is 
Analytically solve Equation (3.14) to find α for each patient at each 
PEEP levels using known variables 
Evaluate the  ∆𝑃𝐴𝐵𝑀𝑃𝑆 using Equation (3.13), (3.12) and (3.11) based 
on the α value over all patients for each PEEP level 
Compare the AUC between ∆𝑃𝐷𝑆𝐴 and ∆𝑃𝐴𝐵𝑀𝑃𝑆 at each PEEP level 
by calculating the minimum average of APE  
Select the optimal α value for each patient that could be applied at all 
PEEP levels based on the least minimum average error 
Known Variables 
∆𝑃𝐷𝑆𝑀, Ln, Dn, 𝑄𝑛 
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the area under the pressure drop curve for all the three models. The AUC of pressure drop 
with respect to time for a single inspiration cycle shown in Figure 6 provides a good single 
value measure of the pressure drop when identifying the patient-specific α. The AUC of 
∆𝑃𝐴𝐵𝑀𝑃𝑆 is compared with AUC of ∆𝑃𝐷𝑆𝐴  for all patients at each PEEP level by calculating 
the minimum average of the absolute percentage error (APE). This comparison ensures the 
model is not over fit to the data but that patient-specific aspects are used to capture and 
represent the fundamental trend. 
 
3.2.4 Patient Data  
 
To compare the three models, retrospective data from 10 acute respiratory distress syndrome 
(ARDS) patients in the Christchurch Hospital Intensive Care Unit (ICU) was used, with the 
data acquisition process detailed in Chapter 2 (Sundaresan et al. 2011a).  The details for each 
patient are shown in Table 3.2.  
 
Table 3.2:  Summary of patient auto-PEEP settings (Sundaresan et al. 2011b). 
Patient  Sex 
Age 
[years] 
Clinical Diagnostic 
Auto-PEEP  
[cmH2O] 
S1 Female 61 Peritonitis, COPD 10 
S2 Male 22 Trauma 12 
S3 Male 55 Aspiration 10 
S4 Male 88 Pneumonia, COPD 10 
S5 Male 59 Pneumonia, COPD 12 
S6 Male 69 Trauma 11 
S7 Male 56 Legionnaires 7.5 
S8 Female 45 Aspiration 12 
S9 Male 37 H1N1,COPD 12 
S10 Male 56 Legionnaires, COPD 3 
 
 
45 
 
3.2.5 Data Analysis 
 
To assess model performance, the pressure drop or, more specifically, the area under the 
pressure drop curve (AUC) for inspiration breathing cycle was estimated and compared for 
all three models. AUC was used instead of the sum square error due to its unique ability to 
capture the pressure drop trend shape, as well as its maximum magnitude. Significance tests 
were carried out using paired Wilcoxon rank-sum test.  
 
3.3 Results 
 
The estimated airway resistance for each branch generation is presented in Figure 3.4 for 
each patient. The AUC for all 10 ARDS patients and all 3 models are shown in Table 3.3. It 
is clear that the general ABM has a very large difference compared to the DSA (p<0.05). 
Table 3.4 shows the patient-specific α that relates to the patient specificity and disease state. 
The α values for COPD patients were significantly lower than the other patients in the cohort 
(rank-sum p<0.0001, Kolmogorov-Smirnov p=0.001), indicating a more resistive airway, as 
expected from critically ill ARDS and respiratory failure patients with stiffer and damaged 
lung units. 
 
Figure 3.5 shows the trend of α values for all patients over PEEP = 5 cmH2O, 10 cmH2O and 
15 cmH2O. Figure 3.6 compares the pressure drop curve for one breathing cycle for patient 
S1, as an example, for all three models at PEEP = 5 cmH2O, 10 cmH2O and 15 cmH2O, with 
patient-specific α = 0.57. Figure 3.7 shows the pressure and volume curve for all the three 
models for the same patient and α value in Figure 3.6.  
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Figure 3.4: Airway resistance for each branch for every patient of the ABMps model. 
 
 
Figure 3.5: Comparison of all α values for all patients vs PEEP for ABMps. 
 
0 5 10 15 20 25
0
5
10
15
 Branch generation
 A
ir
w
a
y
 r
e
s
is
ta
n
c
e
, 
c
m
H
2
O
.s
/L
 
 
Healthy human
Patient S1
Patient S2
Patient S3
Patient S4
Patient S5
Patient S6
Patient S7
Patient S8
Patient S9
Patient S10
5 10 15
0.4
0.45
0.5
0.55
0.6
0.65
 PEEP,cmH
2
O
 A
lp
h
a
 
 
Patient S1
Patient S2
Patient S3
Patient S4
Patient S5
Patient S6
Patient S7
Patient S8
Patient S9
Patient S10
47 
 
Table 3.3: AUC of airway pressure drops for Sundaresan’s patients (Sundaresan et al. 
2011a), with PEEP = 5, 10 and 15 cmH2O for general ABM, ABM-specific and DSA. 
 
Patient Auto-
PEEP 
 
(cmH2O) 
PEEP 
 
 
(cmH2O) 
Optimal 
α 
ABMpsAUC  
(cmH2O.s) 
General 
ABM AUC 
 
(cmH2O.s) 
DSA AUC 
 
 
(cmH2O.s) 
Error = 
AUC(ABMps-DSA)  
(%) PEEP 5 
cmH2O 
PEEP 10 
cmH2O 
PEEP 15 
cmH2O 
S1 10 
5 0.51 5.35 5.10 5.18 0.37 5.35 0.14 
10 0.54 4.22 4.02 4.09 0.35 4.02 0.09 
15 0.57 3.44 3.28 3.33 0.36 3.33 0.06 
S2 12 
5 0.63 3.11 3.03 2.79 0.50 3.11 0.13 
10 0.64 2.99 2.91 2.68 0.49 2.91 0.10 
15 0.63 3.18 3.10 2.86 0.45 2.86 0.19 
S3 10 
5 0.62 2.89 2.84 2.62 0.42 2.89 0.11 
10 0.63 2.63 2.58 2.38 0.41 2.58 0.08 
15 0.63 2.73 2.68 2.47 0.38 2.47 0.15 
S4 10 
5 0.45 10.0 9.66 10.30 0.40 10.00 0.21 
10 0.47 8.20 8.05 8.36 0.40 8.05 0.16 
15 0.50 6.59 6.52 6.77 0.41 6.77 0.15 
S5 12 
5 0.46 8.82 8.45 7.92 0.41 8.82 0.42 
10 0.50 6.76 6.48 6.07 0.39 6.48 0.23 
15 0.54 4.79 4.59 4.30 0.37 4.30 0.26 
S6 11 
5 0.63 3.03 2.92 2.92 0.46 3.03 0.07 
10 0.64 2.82 2.72 2.72 0.44 2.72 0.04 
15 0.64 2.80 2.70 2.70 0.44 2.70 0.03 
S7 7.5 
5 0.66 1.80 1.84 1.83 0.34 1.80 0.03 
10 0.64 1.98 2.03 2.02 0.35 2.03 0.02 
15 0.59 2.81 2.88 2.86 0.34 2.86 0.03 
S8 12 
5 0.56 3.76 3.69 3.71 0.37 3.76 0.04 
10 0.58 3.27 3.20 3.22 0.36 3.20 0.03 
15 0.58 3.09 3.15 3.11 0.36 3.11 0.02 
S9 12 
5 0.53 5.96 6.02 6.01 0.48 5.96 0.04 
10 0.58 4.42 4.46 4.45 0.49 4.46 0.02 
15 0.60 3.74 3.78 3.77 0.49 3.77 0.01 
S10 3 
5 0.59 3.76 3.62 3.70 0.47 3.76 0.07 
10 0.61 3.32 3.20 3.27 0.45 3.20 0.06 
15 0.62 3.15 3.04 3.10 0.46 3.10 0.04 
Mean   0.58    0.41 4.12 0.07 
[IQR]   [0.54-0.63]    [0.37-0.46] [3.20-4.42] [0.03-0.15] 
 
Table 3.4: Patient-specific α vs disease state. 
 
Number 
of 
Patients  
Clinical Diagnostic Range of α 
5 COPD 0.45 – 0.62 
2 Aspiration 0.56 – 0.63 
2 Trauma 0.63 – 0.64 
1 Legionnaires 0.59 – 0.66 
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a) 
 
   b) 
 
  c) 
  
Figure 3.6: Comparison of airway pressure drop for one breathing cycle for patient S1 with COPD for 
general ABM, ABMps, and DSA with α = 0.57. Plot of general ABM, ABMps, and DSA at (a) PEEP = 
5cmH2O (b) PEEP = 10cmH2O, and (c) PEEP = 15cmH2O. 
 
 
    a)   PEEP = 5 cmH2O 
 
    b)   PEEP = 10 cmH2O 
 
    c)   PEEP = 15 cmH2O 
 
Figure 3.7: Comparison of pressure volume curve for patient S1 with COPD for general ABM, ABMps, 
DSA, and actual inspiration with α = 0.57. 
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3.4 Discussion 
 
It can be observed in Figure 3.4 that the airway resistance is higher at the trachea (generation 
0) and 5
th
 generation branch for all patients. Initially, the resistance starts to drop from 
generation 0, which is the trachea, up to generation 4. The resistance starts to rise at 
generation 5 as the length of the bronchial tube is higher at this generation compared to the 
previous branches (Pedley et al. 1970). Airway obstructions increase the airway resistance, as 
seen in Figure 3.3, where for COPD patients, S1, S4, S5, S9 and S10, the airway resistances 
were higher compared to the healthy human and other patients. With the increased airway 
resistance in COPD patients, these results clearly show that a higher resistance results in the 
higher airway pressure drop observed, and thus the consequent reduced volume. This 
estimation of airway resistance by the ABMps cannot be done by using the DSA model and 
highlights a useful feature of this approach.  
 
With the patient-specific α value, the airway resistance can be estimated, which leads to 
estimating the pressure drop. Furthermore, the airway resistance for each patient is different 
and shows that airway resistance is higher for COPD patients as expected until their auto-
PEEP pressure is exceeded opening new lung volume. Thus, this ABMps can be used to 
detect the disease state independently or automatically, which could not be done by the DSA.    
 
The estimated airway pressure drop using the patient-specific ABMps with α value was 
significantly different from the pressure drop estimated using the general ABM (p<0.05). 
Table 3.3 shows that AUC pressure drop in the general ABM typically exhibited very large 
differences for all patients at all PEEP levels compared to the DSA with p<0.05. In contrast, a 
good comparison is observed between the AUC of pressure drops in ABMps and DSA in 
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Tables 3.3 and Figure 3.6. This result clearly shows that the general ABM does not capture 
the observed mechanics of critically ill mechanical ventilation patients despite it being a mix 
of classical mechanics and measured behaviour (Damanhuri et al. 2012). However, if it is 
extended with patient-specific α, it is a far better representation of the patient-specific airway 
dimension. In addition, these patient-specific aspects dominate the differences from the 
general ABM modelling approach to matching the patient-specific DSA results. This last 
result matches the inter-patient variability noted in MV patients as a whole, and shows the 
need for a patient-specific approach to estimated model-based alveolar pressures in this 
cohort. 
 
Figure 3.6 illustrates an example of estimated pressure drops for Patient S1 between general 
ABM, ABMps and DSA models. With α = 0.57 at PEEP = 15 cmH2O, the AUC of pressure 
drop for Patient S1 in ABMps and DSA yields the same result of 3.33 cmH2O.s, where the 
general ABM yields a far lower 0.36 cmH2O.s. This difference indicates that the ABMps was 
able to predict the same airway pressure drop as the DSA by incorporating the α term that 
was unique for each specific patient’s branching system. Equally, the general ABM, as 
defined in Table 3.2, is not capable of accurately capturing the observed mechanics in 
mechanical ventilation patients with significant respiratory dysfunction and failure. This 
difference, and small α < 1.0 value are due to the respiratory failure status of these patients 
limiting lung volume and creating a stiffer, smaller, and thus more resistive lung. 
 
From Tables 3.3 and 3.4, it is also noted that all α values for all patients are less than 1.0. 
Therefore, all pulmonary paths have a smaller diameter than the expected diameters from 
Table 3.2.  This finding reflects the clinical condition of these patients. In particular, patients 
with restrictive airway conditions, such as Chronic Obstructive Pulmonary Disease (COPD), 
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have constricted airways and respiratory failure by definition. Thus, α is smaller 
comparatively (α =0.45-0.62) than would be assumed for a healthy individual, per Table 3.2. 
Smaller α values also occurred in aspiration patients (α =0.56-0.63) where the restrictive 
airway condition of the lung is developed due to the entrance of foreign materials into the 
bronchial generations. Thus, with the use of α, the ABMps is not only able to capture similar 
alveolar pressure as DSA but is it also able to track patient disease state over time as shown 
in Table 3.4 and Figure 3.5. The greater airway resistance modelled with α < 1.0 results in 
higher pressure drops at the alveoli, as expected, and is thus a better match with the DSA. In 
addition, ARDS patients are often associated with regional airway collapse (Halter et al. 
2007) at higher branch generations, which will also greatly alter the airway resistance (Pedley 
et al. 1970) and supports the overall interpretation presented for these patient-specific results.  
 
Equally, the inspiration pressure volume curve for the general ABM and the ABMps can be 
modelled and compared with the DSA curve and the actual dynamic inspiration pressure 
volume curve, as shown in Figure 3.7. The general ABM does not capture alveoli pressure 
like the DSA in critically ill patients. The general ABM would look a lot like the inspiration 
curve in Figure 3.7 and shifted slightly to lower pressure.  This outcome occurs because the 
∆𝑃 drops are 10 times smaller than the ∆𝑃 drops in the ABMps in Table 3.3. Thus, the 
general ABM was not effective at capturing the estimated alveoli pressure volume curve in 
this cohort.  
 
Both the ABMps and DSA take into account the airway resistance that occurs in the lung and 
leads to the airway pressure drop. Furthermore, the ABMps is designed with minor loss and 
patient-specific airway dimensions based on the α value, that is unique for each patient. 
Hence, in Figure 3.6 the pressure volume curve for the ABMps is very similar to the DSA as 
52 
 
PEEP increases from 5 cmH2O to 15 cmH2O with the patient-specific α = 0.57. Although the 
ABMps had smaller error in comparison to the DSA at lower PEEP, this inspiration pressure 
volume curve could still be applied as a guidance tool for clinicians to provide a better 
solution for mechanically ventilated patients. 
 
Although the ABMps estimates pressure drops at every physiological airway branch, there 
are limitations to its predictive capability. This ABMps assumes that the bifurcations run 
throughout the entire generations from the 1
st
 generation up to the 23
rd
 generation based on 
physiological measurements and assumption by referring to the Weibel et al. model, which 
has been used widely in deterministic studies (Katz 2012; Pedley et al. 1970; Weibel 1963a). 
However, this assumption may not be applied in real scenarios if one or more of the bronchial 
paths are blocked as in COPD. 
 
Nevertheless, the ABMps with the patient specific α value is capable to show that every 
patient has α < 1.0, which reflects that patient’s pulmonary paths have a reduced equivalent 
diameter that results in a different resistance as compared to the healthy human physiological 
measurements. This reduced equivalent diameter thus is a surrogate that captures the 
(variable) clinical condition of each patient and potential smaller volume. For example, 
COPD patients have a blockage of bronchial portions of the lungs that reduce volume. In 
contrast, respiratory failure or ARDS patients may experience a similar total loss of lung 
volume due to collapsed alveoli distributed throughout the lung. However, in both cases, 
adjustment to MV settings may be needed to try to recruit this lost volume, and, equally, in 
both cases, additional pressure is the typical mechanism used for this recruitment.   
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In this research, the ETT dimensions were the same across all patients. However, while ETT 
dimensions may vary between patients, the ABMps remains capable of estimating this 
pressure drop so that an accurate estimation of the pressure drop in the deep bronchial paths 
can be used for predicting the alveolar pressure drop. The ETT dimensions are typically 
known, and were consistent in this research, thus maintaining the ability to estimate this 
alveolar pressure drop, which is important if it is to be used to avoid and prevent further lung 
injury due to the provision of excessive pressure. Simply, there is no loss of generality from 
the consistent and typical adult ETT dimensions used here. 
 
Although an average value of minor loss coefficient is used in this model, the ABMps was 
able to capture the pressure drop in the airway branching system. In addition, at the very low 
flows at the later generations, the contributions to pressure drop of these minor loss 
coefficient constants are almost negligible (Katz et al. 2011). Thus, the use of this average 
value of minor loss coefficient and an ETT specific loss capture much of the loss seen. 
Equally, while a distribution of loss coefficients based on anatomical studies could be used, it 
cannot be validated given the limited measurements of pressure and flow available in 
pulmonary medicine. Thus, given these points, an average value is used because it captures 
the overall losses and pressure drops, even if intermediate pressures may not be fully 
accurate, and thus provides a good estimate of alveolar pressure, which is the main goal of 
this model. 
 
With the use of α, the ABMps was able to capture similar alveolar pressure as the DSA with 
further insight of patient-specific airway dimensions during mechanical ventilation. However, 
due to limited patient data, the application of α as a surrogate of patient-specific condition 
was not fully validated, although the concept was demonstrated. In particular, as a patient 
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recovers from ARDS, the regional collapsed alveoli may be recruited, resulting in a change in 
patient airway condition that would be seen in a change in the effective value of α. Thus, the 
clinical utility of patient-specific α in tracking patient disease state warrants further 
investigation over larger cohorts given this initial set of results. 
 
3.5 Summary 
 
In this chapter, the study assesses the efficacy of a physically derived ABM to capture 
clinical data. The ABM significantly underestimates the total pressure drop from trachea to 
the alveoli. Thus, with a patient-specific airway branching model, it is able to assess the 
pressure drop of the airway more accurately using clinically available airway pressure and 
flow measurements. Using this model, the airway condition of a patient can be characterised 
and thus, could provide clinically useful information to clinicians to guide patient-specific 
therapy. This results show that even though the ABMps model is derived via classical simple 
Poiseuille flow and minor loss equations, the extension to a patient-specific airway 
dimension, α, produced consistent trends and compared well to the DSA model as the current 
standard for estimating alveolar pressures. This α value can be easily calculated at the bedside 
in a similar fashion to offer additional insight beyond the DSA with respect to potential to 
recruit volume (increase in α after a change in treatment) and to monitor patient condition. 
Overall, these results provide a general model framework that can be customised to each 
patient at the bedside to help guide care. The results justify further prospective trials to assess 
the clinical utility of patient-specific value of α in assessing patient condition. 
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CHAPTER 4 
Application of Lung Elastance in Mechanical Ventilation 
 
4.1 The concept of lung elastance 
 
One of the important metrics that can be used in managing mechanical ventilation (MV) is 
monitoring the lung elastance of ARDS patients. Elastance changes with patient condition 
since injured lung tissue, combined with a build-up of fluid, affects the resulting elasticity of 
the lungs (Gattinoni & Pesenti 2005). Elastance is a measure of the tendency of the lung to 
recoil to its original form and is the reciprocal of compliance. In particular, ARDS affected 
lungs have relatively higher elastance and significantly more hysteresis compared to healthy 
lungs, and has been used in other studies to assess the level of lung injury (Suarez-Sipmann et 
al. 2007; The ARDS Definition Task Force 2012).  
 
Other studies have shown that a more optimal MV setting occurs when the lung is inflated at 
the minimum inspiratory elastance (Carvalho et al. 2007; Chiew et al. 2011; Lambermont et 
al. 2008; Suarez-Sipmann et al. 2007). Specifically, lung volume is achieved with minimal 
added pressure, which implies maximum oxygenation for a minimum change in lung pressure 
or stress. Thus, models that capture patient-specific lung elastance (1/compliance) and 
recruitment can provide insight into otherwise un-measurable metrics of lung condition, 
thereby aiding clinical decision making (Chase et al. 2006a; Chiew et al. 2011; Sundaresan et 
al. 2011a; Sundaresan et al. 2009).  
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In addition, considering how elastance changes within the breath and throughout patient care, 
provides a new clinical perspective. Thus, it provides a non-invasive method that could 
provide real-time monitoring of lung condition based on measurement of lung elastance. 
Since this approach adds no additional sensors or cost, and provides a useful measure, it 
could be used to guide clinicians in PEEP titration to obtain optimal MV settings.  
 
In this chapter, two model-based methods are introduced to estimate lung elastance in ARDS 
patients. 
 
4.2 Elastance estimation using single compartment lung model 
 
Lumped parameter respiratory system models offer a simple and relatively inexpensive 
method of assessing lung mechanics and/or gas exchange, and thus, for capturing essential 
respiratory dynamics. Lumped parameter models can be computationally implemented 
directly at the bedside and are thus clinically viable. One of the most commonly used lumped 
parameter models is the single compartment lung model (Mead & Whittenberger 1953). The 
single compartment lung model, as shown in Figure 4.1, is modelled as a combination of an 
elastic and resistive component that uses readily measurable airway pressure (Paw), lung 
volume (V), and air flow (Qaw) to estimate the overall respiratory elastance (Ers) and overall 
respiratory resistance (Rrs) (Bates 2009) .  
 
Using standard mechanics, the respiratory system model can be defined: 
𝑃𝑎𝑤 (𝑡) =  𝑅𝑟𝑠𝑄𝑎𝑤(𝑡) +  𝐸𝑟𝑠𝑉(𝑡) +  𝑃0 (4.1) 
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where 𝑃0 is the offset pressure. 𝑃0 is usually zero at atmospheric pressure but it will change 
when PEEP is applied and can also account for Auto-PEEP (Bates 2009). The airway 
pressure (𝑃𝑎𝑤 ) comprises the sum of the pressure drop due to the resistance component of the 
endotracheal tube (ETT) and patient’s branching airway (Damanhuri et al. 2014), the pressure 
required to overcome the elastic tendencies of the lung tissues, and the offset pressure. 
Patient-specific respiratory elastance (Ers) reflects the lung stiffness and can be identified 
from measured data. Thus, a lower Ers indicates a more compliant lung. 
 
 
Figure 4.1: The single compartment schematic diagram of the lung mechanic system. 
 
The physiological relevance of the identified model parameters depends on the simplifying 
assumptions of the model. In this model, the integral-based method (Hann et al. 2005) is used 
to identify the parameters 𝐸𝑟𝑠 and 𝑅𝑟𝑠 that best fit Equation 4.1 using the measured 
inspiratory pressure (Paw) and air flow (Qaw) from each breathing cycle. Integral-based 
𝐸𝑟𝑠 
𝑅𝑟𝑠 
𝑉(𝑡) 
∆𝑃(𝑡) 
𝑄𝑎𝑤(𝑡), 𝑃𝑎𝑤(𝑡) 
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parameter identification is similar to multiple linear regression, where using integrals 
significantly increases robustness to noise (Chiew et al. 2011; Hann et al. 2005). 
∫ 𝑃𝑎𝑤(𝑡) =  𝑅𝑟𝑠 ∫ 𝑄𝑎𝑤(𝑡) +  𝐸𝑟𝑠 ∫ 𝑉(𝑡) + ∫ 𝑃0 
(4.2) 
 
Chiew et. al (Chiew et al. 2011) based their model development on a concept of minimal 
elastance during recruitment of the lung. During each breathing cycle, as pressure rises for a 
given PEEP level, Ers is decreasing as new lung volume is recruited faster than pressure can 
build up in the lung. This response indicates recruitability of the lung. If there is little or no 
recruitment, Ers rises with pressure, which indicates that the inspiratory pressure was unable 
to recruit new lung volume, leading to increased stress and risk of ventilator induced lung 
injury (VILI). Thus, the already recruited lung is stretched and possibly damaged. Hence, by 
monitoring patient-specific and breath-specific respiratory elastance during changes in PEEP 
level can provide insight into patient condition, help guide MV setting of PEEP, and prevent 
lung injury.  
 
4.3 Time varying elastance model 
 
Time varying elastance (Edrs), as proposed by Chiew et. al (Chiew et al. 2011), is an 
extension of respiratory system elastance (Ers) with the aim of providing a higher resolution 
metric for use in guiding optimal PEEP selection. It is an in-breath-specific respiratory 
elastance over an inspiratory time period that can potentially provide further unique insight 
into patient-specific lung condition and response to MV settings (Carvalho et al. 2006; Chiew 
et al. 2011; Kárason et al. 2001). Furthermore, the minimum value of Edrs during PEEP 
titration can aid, as with Ers, in identifying an optimal patient-specific PEEP to help the 
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patient reduce the work of breathing (WOB) and maximise recruitment of the lung without 
further lung injury (Marini et al. 1985; Otis et al. 1950).  
 
By calculating the value of Edrs over each breath, it is possible to identify the change of 
respiratory elastance within a breathing cycle as a function of PEEP and pressure over that 
breath. A decreasing value of Edrs over a breath indicates recruitment over pressure build up, 
while an increasing value of Edrs suggests poor recruitment (Chiew et al. 2011). By 
identifying the time-variant of Edrs over each breath, it allows the clinicians to see the 
changes in lung dynamically with each breathing cycle as pressure increases and thus 
provides a more detailed view of patient lung condition. This type of information cannot be 
provided by the calculation of a single value of Ers averaged over a breath. Thus, the 
estimation of Edrs provides more information and higher resolution in patient monitoring. 
 
To investigate the variability of respiratory elastance, the modified single compartment lung 
model is used. This model incorporates Edrs to capture patients-specific and breath-specific 
respiratory mechanics, including those with spontaneous breathing (SB) effort. This model 
also proposes negative and positive components for the respiratory elastance (Chiew et al. 
2015), when considering SB efforts, where the positive component within a short time period 
during inspiration is assumed to be effectively constant over the breath. In contrast, the 
negative component is variable depending on how strongly the patient initiates the breathing 
cycle, representing a significant patient-and breath- specific, unknown that is typically an 
unmeasurable quantity without significant, added and invasive sensors.  
 
The single compartment lung model in Equation 4.1 includes all resistive and elastic 
components of the respiratory system for a fully sedated patient (Bates 2009). To account for 
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patients with spontaneous breathing respiratory mechanics, the term, respiratory elastance 
(Ers), is replaced with a time-varying elastance (Edrs) that is comprised of 3 subcomponents 
including: the cage elastance (Ecw), the demand elastance (Edemand) and the lung elastance 
(Elung). These terms are then defined: 
𝐸𝑑𝑟𝑠(𝑡) =  𝐸𝑐𝑤(𝑡) +  𝐸𝑑𝑒𝑚𝑎𝑛𝑑 (𝑡) +  𝐸𝑙𝑢𝑛𝑔(𝑡) (4.2) 
 
𝑃𝑎𝑤(𝑡) =  (𝐸𝑐𝑤(𝑡) +  𝐸𝑑𝑒𝑚𝑎𝑛𝑑 (𝑡) + 𝐸𝑙𝑢𝑛𝑔(𝑡))𝑉(𝑡) + 𝑅𝑟𝑠𝑄(𝑡) (4.3) 
 
𝑃𝑎𝑤(𝑡) =  𝑃𝑐𝑤(𝑡) + 𝑃𝑑𝑒𝑚𝑎𝑛𝑑 (𝑡) + 𝑃𝑙𝑢𝑛𝑔(𝑡))𝑉(𝑡) + 𝑃𝑟𝑠 
 
(4.4) 
where Elung is a measure of the elastic properties of the lung or the collection of alveoli. Elung 
decreases if overall alveoli recruitment outweighs the pressure build-up. Elung will increase if 
the overall alveoli are stretched with lesser or no further recruitment (Chiew et al. 2011). 
Thus, Elung is the representation of true lung mechanics that captures the patient-specific 
response to MV in each breathing cycle and thus also provides an indication of the patient 
disease state (Chiew et al. 2015). The elastic properties of the chest wall (Ecw) in Equations 
4.3-4.5 consist of the stiffness contribution mode by the rib cage and intercostal muscles. 
This elastance subcomponent can be assumed not to vary with disease-state and is thus 
considered a patient-specific constant (Chiumello et al. 2008). Finally, Edemand represents the 
unmeasured patient-specific inspiratory demand, which varies depending on patient-specific 
and breath-specific effort. This elastance is negative (Edemand <0) as it represents the reduced 
apparent elastance seen in measured Paw and Qaw that is due to the patient-specific and 
breath-specific inspiratory effort creating a pressure reduction in the measured Paw delivered 
by the ventilator that is used or needed to open the lung. Table 4.1 provides a further 
nomenclature.  
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Table 4.1: List of abbreviation 
 
 Units Definition 
Paw cmH2O Airway pressure 
Ppl cmH2O Pleural pressure (oesophageal pressure) 
Pcw cmH2O Chest wall pressure 
Pdemand cmH2O Demand pressure 
Plung cmH2O Lung pressure during MV 
Prs cmH2O Pressure drop due to respiratory system resistance 
Ers cmH2O/l Respiratory system elastance 
Ecw cmH2O/l Cage elastance 
Edemand cmH2O/l Demand elastance 
Elung cmH2O/l Lung elastance 
Rrs cmH2O/l Respiratory system resistance 
Rlung cmH2O.s/l Lung resistance 
Rcw cmH2O.s/l Chest wall resistance 
 
 
A schematic representation of this extended compartment model is shown in Figure 4.2. 
 
 
Figure 4.2: The measured airway pressure consists of 4 pressure components: 1) Pressure 
drop due to airway resistance (Prs), 2) pressure in the lung compartments (Plung), 3) and 4) 
pressure change in the pleural space (Pcw + Pdemand). 
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Pcw and Pdemand are the pressure components generated from Ecw and Edemand. Combining these 
pressure components will thus give information on the pleural pressure (Ppl), which is the 
pressure change in the pleural space (chest wall). Plung is the pressure in the lung during MV 
and Prs is the pressure drop due to the conducting airway. Again, all these terms are also 
shown in Table 4.1. 
 
In a fully sedated patient, Edrs values were always positive (Edrs > 0) and had similar elastance 
to ARDS patients (Carvalho et al. 2008; Chiew et al. 2011; Suarez-Sipmann et al. 2007) as 
there was no external energy input from SB efforts. However, if the patient exhibits 
spontaneous inspiratory effort, this value will reduce Edrs (t) to become negative due to 
Edemand (Edemand < 0). The negative value of Edemand will decrease the overall values of Edrs and 
result in variability in the overall respiratory elastance. As patient demand aids breathing 
effort, the effective overall airway pressure is thus reduced from sedated state (Damanhuri et 
al. 2015). In any given breathing cycle, the time-varying Edrs of Equation 4.3 captures all 
three elastance components together, and thus a general conceptual and modelling approach 
is created in this analysis. 
 
It is important to note that Edrs, is an overall, effective elastance. It is assessed as the change 
in pressure for a given tidal volume of flow. Thus, lower effective elastance implies less risk 
of lung damage (Carvalho et al. 2007; Chiew et al. 2011). This non-invasive model-based 
monitoring and analysis method is hypothesized to be able to capture new insight into the 
dynamic respiratory mechanics, particularly for SB patients during fully controlled or 
partially assisted MV modes. This model is validated to investigate further on the negative 
elastance in SB patients using clinical data, and is presented in Chapter 7.  
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4.4 Summary 
 
Lung elastance is an important parameter used to quantify the condition and response to 
therapy of a patient suffering from respiratory failure. With the estimation of the lung 
elastance (Ers), the effect of PEEP on lung elastance has a potential for guiding MV therapy. 
The time varying elastance model provides more robust method to determine the dynamic 
lung condition in fully sedated and SB patients. The estimation of Edrs allows a more true 
measurement of dynamic lung elastance over the inspiration cycle that cannot be provided by 
a single average value of Ers. 
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CHAPTER 5 
Expiratory Time Constant Model Using Clinical Data 
 
5.1 Introduction 
 
Respiratory system models can provide real-time information on patient condition and 
response to treatment based on mechanical ventilation (MV) airway pressure (Paw) and flow 
(Qaw) data (Chiew et al. 2011; van Drunen et al. 2014). However, most respiratory mechanics 
models require specific data profiles and specialised, often invasive and/or interruption of 
care, protocols for model identification (Oostveen et al. 2003; Schranz et al. 2012a; Schranz 
et al. 2011; Stahl et al. 2006). These models also focused only on data collected during 
inspiration, and data during expiration are essentially neglected. Recent research conducted 
by Al Rawas et al. (2013) and van Drunen et al. (2013) on expiratory data had found high 
correlation between the inverse expiratory time constant and respiratory system elastance in 
both human and experimental animal trials. These finding have led to a potential to use of the 
expiratory data during clinical respiratory mechanics monitoring to guide MV.  
 
In particular, the study by van Drunen et al. (van Drunen et al. 2013) has shown that the 
inverse of expiratory time constant parameter (K) provides potential ability to track changes 
in disease state throughout therapy (van Drunen et al. 2013). In this animal study, trends in K 
were comparable to respiratory elastance trends obtained using the invasive end-of 
inspiratory pause method (Estatic) that interrupts care, as well as respiratory elastance derived 
from the single compartment lung model (ErsIB). These outcomes are shown in Figure 5.1.  
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The top of Figure 5.1 shows the result from a phase 2 condition, which is defined as a 
progression from a healthy state to an induced ARDS state at a constant PEEP, where the 
bottom figure shows the results of phase 3, which is an induced ARDS state staircase 
recruitment manoeuvre (RM). In both phases, ErsIB, Estatic, and K followed similar trends. 
Hence, these results show that the expiratory time constant model was able to identify trends 
and fundamental changes in respiratory mechanics, as determined by the invasive end-
inspiratory pause method and the single compartment linear lung model. 
 
 
 
Figure 5.1: Top Respiratory system mechanics monitoring during phase 2, disease 
progression for animal data 1. Bottom Respiratory system mechanics monitoring during phase 
3, disease state recruitment manoeuvre for animal data 1. Note that values of K have been 
scaled for clarity and serve only as an indication for trend comparison. 
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This chapter extends the investigation on the relation of expiratory time constant with 
respiratory system elastance using retrospective clinical cohorts (Bersten 1998; Sundaresan et 
al. 2011a). These data are comprised of step-wise recruitment manoeuvres (RM) with PEEP 
changes to provide a variation of respiratory system elastance response to different PEEP 
levels (Chiew et al. 2011). These respiratory system elastance variations thus provide a 
unique platform to investigate the relation of expiratory time constant with respiratory system 
elastance. Importantly, information on respiratory system elastance response to PEEP has 
shown clinical potential for guiding PEEP titration (Carvalho et al. 2007; Carvalho et al. 
2008; Carvalho et al. 2013; Lambermont et al. 2008; Suarez-Sipmann et al. 2007; Suter et al. 
1978; Zhao et al. 2010a). Thus, a good correlation between these metrics will imply that the 
expiratory time constant can also be used to titrate PEEP under similar assumptions (van 
Drunen et al. 2013) using easily measured, non-invasive data, and without interrupting care. 
 
5.2 Methodology 
5.2.1 Expiratory Time Constant Model 
 
The expiration process is defined as a passive process, where the lung and chest wall are 
elastic and have a tendency to return to their equilibrium positions after being actively 
inflated during inspiration. The single compartment lung model, as mentioned earlier in 
Chapter 4, is only focused on the inspiration cycle because inspiration and expiration are two 
different physiological processes that must be considered separately when determining lung 
properties (Möller et al. 2010). The equation of respiratory system is repeated here for clarity 
as: 
𝑃𝑎𝑤 (𝑡) =  𝑅𝑟𝑠𝑄𝑎𝑤(𝑡) +  𝐸𝑟𝑠𝑉(𝑡) +  𝑃0 (5.1) 
 
67 
 
Thus, the expiratory time constant model is derived from the single compartment lung model, 
but focuses on expiration data. van Drunen et al. (2013) proposed a method of calculating the 
inverse of time constant parameter (K) during the expiration cycle time.  
 
It is important to note that expiration is a passive process that unloads the inspired tidal 
volume over a resistance at a constant ventilator applied end expiratory pressure (𝑃𝑎𝑤= PEEP) 
with 𝑃0 = PEEP (Möller et al. 2010). Thus, Equation 5.1 in expiration becomes: 
𝑃𝐸𝐸𝑃 =  𝑅𝑟𝑠𝑄𝑎𝑤(𝑡) +  𝐸𝑟𝑠 ∫ 𝑉(𝑡)𝑑𝑡 +  𝑃𝐸𝐸𝑃 
(5.2) 
 
Differentiating Equation 5.2 yields: 
0 =  𝑅𝑟𝑠
𝑑𝑄𝑎𝑤(𝑡)
𝑑𝑡
+ 𝐸𝑟𝑠𝑄𝑎𝑤(𝑡) 
(5.3) 
 
By dividing Equation 5.3 with 𝑅𝑟𝑠, a simple differential equation is yielded: 
0 =
𝑑𝑄(𝑡)
𝑑𝑡
+ 
𝐸𝑟𝑠
𝑅𝑟𝑠
𝑄𝑎𝑤(𝑡) 
(5.4) 
 
Hence, the expiratory time constant model derived from the single compartment lung model 
is defined: 
𝑄𝑎𝑤(𝑡) =  𝑄0𝑒
𝑡
𝜏⁄ = 𝑄0𝑒
−𝐾𝑡 (5.5) 
 
where 𝑄0 is the value of maximum expiratory flow and τ = 1/K = 𝑅𝑟𝑠/𝐸𝑟𝑠 is the time constant 
for this model during expiratory time (Al-Rawas et al. 2013).  
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Figure 5.2: Example of how expiratory flow profiles over time may be used to determine 
changes in a patients’ disease state, assuming Rrs is constant. 
 
If 𝑅𝑟𝑠 is assumed constant (Chiew et al. 2011), the parameter K is directly proportional to 𝐸𝑟𝑠 
where an increasing K implies a stiffer lung as ARDS progresses, as illustrated in Figure 5.2. 
 
5.2.2 Patient Data 
 
This model is assessed using two retrospective clinical ARDS cohorts, consisting of 10 
patient-datasets from Sundaresan et al. (Sundaresan et al. 2011a) and 12 patients-datasets 
from Bersten et al. (Bersten 1998), denoted Cohorts 1 and 2, respectively. The associated 
protocols have been described in detail in Chapter 2.  
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5.2.3 Analysis 
 
The expiratory time-constant model parameter, K, is calculated continuously for every 
breathing cycle at each PEEP level for both cohorts (Bersten 1998; Sundaresan et al. 2011a) 
based on flow rate and airway pressure data respectively. Validation is performed by 
comparing trends of the estimated K values during expiration cycle to trends of Ers/Rrs and Ers 
during inspiration cycle that derived from the single compartment lung model. Results of K, 
Rrs, Ers/Rrs, and Ers are recorded in Median and Inter-Quartile Range (IQR). Furthermore, 
performance was assessed by calculating the Pearson correlation coefficient (R
2
) where trend 
comparisons between the estimated K for expiration, and both Ers/Rrs and Elung for inspiration 
were made. Good correlation results will indicate similarity as often assumed. In contrast, 
poor correlation results will show the need to treat them separately.  
 
5.3 Results 
 
Correlation between K and inspiration derived Ers are compared and shown in Figure 5.3 for 
both Cohorts 1 and 2. The Pearson correlation for K- Ers for Cohort 1 is R
2 
= 0.568, Cohort 2 
is R
2
 = 0.184 and the overall value is R
2
 = 0.435. Figure 5.4 illustrates the correlation 
between K and inspiration derived Ers/Rrs for both Cohorts 1 and 2 with a correlation results 
K- Elung/Rlung is R
2
 = 0.340 for Cohort 1 and R
2
 = 0.002 for Cohort 2 and R
2
 = 0.078 all 
together. The Median and Inter-Quartile Range (IQR) of Ers, Rrs, Ers/Rrs and, K for each data 
set from both cohorts are tabulated in Tables 5.1 (Cohort 1) and 5.2 (Cohort 2), respectively.  
 
Figure 5.5 and 5.6 present the changes of Ers comparing to expiratory time constant K with 
PEEP increase for both Cohort 1 and Cohort 2. Figure 5.7 compares the trend of Rrs between 
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a Chronic Obstructive Pulmonary Disease (COPD) patient and a non COPD patient for all 
PEEP levels from Cohort 1. Figure 5.8 shows the trend comparison of expiration time 
constant, K, inspiration Ers and inspiration Ers/Rrs between Patient S1 from Cohort 1 and 
Patient B10 in Cohort 2 for all PEEP levels at every breathing cycle. The model-fitting for 
airway flow and pressure between measured and calculated values for dataset S3 are depicted 
in Figure 5.8. 
 
Figure 5.3: Correlation plots of K vs Ers for both all data sets with R
2
 = 0.568 for Cohort 1 
and R
2
 = 0.184 for Cohort 2 and R
2
 = 0.435 for both Cohorts at all PEEP levels. 
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Figure 5.4: Correlation plots of K vs Ers/Rrs for both all data sets with R
2
 = 0.340 for Cohort 1 
and R
2
 = 0.002 for Cohort 2 and R
2
 = 0.078 for both Cohorts at all PEEP levels. 
 
Table 5.1: Median and IQR of Ers, Rrs, Ers/Rrs, and, K of each dataset from Cohort 1 
(Sundaresan et al. 2011a). 
 
 Median [IQR] 
Dataset Ers(cmH2O/L) 𝑹𝒓𝒔(cmH2O.s/L) 𝑬𝒓𝒔/𝑹𝒓𝒔(1/s) 𝑲(1/s) 
S1 32.54 
[27.51-37.24] 
10.65 
[9.59-15.87] 
2.53 
[1.74-3.76] 
1.33 
[1.30-1.34] 
S2 23.13 
[21.31-26.17] 
7.66 
[7.55-8.25] 
3.03 
[2.50-3.46] 
1.31 
[1.29-1.34] 
S3 20.70 
[18.05- 26.81] 
6.70 
[6.17-7.45] 
2.86 
[2.33-4.37] 
1.34 
[1.27-1.41] 
S4 25.04 
[19.38-27.04] 
19.68 
[16.10-23.07] 
1.15 
[1.04-1.42] 
0.93 
[0.51-1.50] 
S5 44.54 
[42.32-49.21] 
16.11 
[11.54-23.98] 
2.52 
[2.03-3.72] 
2.37 
[1.93-3.01] 
S6 24.84 
[24.49-30.22] 
5.65 
[5.26-6.40] 
4.32 
[3.80-5.77] 
1.62 
[1.44-1.68] 
S7 59.70 
[47.16-81.18] 
4.59 
[4.22-5.09] 
11.74 
[10.27-19.25] 
3.98 
[3.52-4.44] 
S8 29.11 
[27.51-32.20] 
7.24 
[6.66-9.25] 
3.65 
[3.03-4.37] 
1.81 
[1.76-2.01] 
S9 27.97 
[25.07-30.09] 
6.45 
[6.21-10.86] 
3.83 
[2.44-4.62] 
1.57 
[1.49-1.72] 
S10 37.18 
[36.36-41.86] 
5.75 
[5.57-8.06] 
6.42 
[4.61-7.11] 
2.15 
[1.75-2.27] 
Median 
[IQR] 
29.40 
[24.63-37.47] 
7.78 
[6.02-12.72] 
3.50 
[2.18-5.37] 
1.57 
[1.33-1.99] 
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Table 5.2: Median and IQR of Ers, Rrs, Ers/Rrs, and K of each dataset from Cohort 2 
(Bersten 1998). 
 
 Median [IQR] 
Dataset Ers(cmH2O/L) 𝑹𝒓𝒔(cmH2O.s/L) 𝑬𝒓𝒔/𝑹𝒓𝒔(1/s) 𝑲(1/s) 
          B1 26.23 
[23.47-36.62] 
7.67 
[7.61-7.82] 
3.06 
[2.99-3.43] 
1.18 
[1.14-1.21] 
B2 15.32 
[15.034-16.28] 
7.09 
[6.27-7.59] 
2.18 
[2.15-2.34] 
0.94 
[0.91-0.95] 
B3 32.76 
[30.99-36.63] 
12.69 
[8.83-15.43] 
2.59 
[2.02-4.18] 
1.22 
[1.13-1.26] 
B4 18.27 
[17.478-19.29] 
7.48 
[4.04-11.02] 
3.04 
[1.75-4.32] 
1.49 
[1.31-1.67] 
B5 21.12 
[20.54-21.36] 
7.09 
[5.24-8.33] 
2.86 
[2.47-4.09] 
1.39 
[1.27-1.49] 
B6 33.46 
[32.39-33.70] 
9.95 
[5.33-11.82] 
3.39 
[2.85-5.94] 
1.98 
[1.77-2.10] 
B7 17.18 
[16.26-18.67] 
3.71 
[2.23-4.70] 
5.32 
[3.41-8.68] 
1.16 
[1.07-1.19] 
B8 17.40 
[16.98-20.14] 
11.02 
[10.88-11.30] 
1.55 
[1.50-1.84] 
0.86 
[0.85-0.89] 
B9 32.23 
[29.53-35.21] 
6.69 
[6.49-8.35] 
4.39 
[3.93-5.39] 
1.24 
[1.19-1.28] 
B10 28.90 
[25.43-32.91] 
5.68 
[3.78-7.61] 
5.78 
[3.34-8.71] 
1.20 
[1.17-1.25] 
B11 17.40 
[17.18-18.75] 
3.04 
[1.60-3.15] 
5.64 
[5.49-11.70] 
1.16 
[1.14-1.17] 
B12 24.03 
[23.29-24.77] 
9.70 
[6.80-16.57] 
2.55 
[1.46-3.40] 
1.36 
[1.35-1.45] 
Median 
[IQR] 
23.10 
[17.59-31.48] 
7.43 
[4.88-9.40] 
3.42 
[2.48-4.40] 
1.20 
[1.13-1.34] 
 
Figure 5.5: Ers-PEEP and K-PEEP plot for Cohort 1. Top Ers range for 10 patients in Cohort 1 
with PEEP increase. Bottom K range for 10 patients from Cohort 1 with PEEP increase. 
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Figure 5.6: Ers-PEEP and K-PEEP plot for Cohort 2. Top Ers range for 12 patients in Cohort 2 
with PEEP increase. Bottom K range for 12 patients from Cohort 2 with PEEP increase. 
 
 
Figure 5.7: Comparison of Rrs between dataset S3 which is a non COPD patient with dataset 
S4 which is a COPD patient for all PEEP levels. 
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Figure 5.8: Left Trend comparison of expiration time constant, K, inspiration Ers/Rrs and 
inspiration Ers/Rrs for one breathing cycle for patient S1 from Cohort 1 for all PEEP levels. 
Right Trend comparison of expiration time constant, K, inspiration Ers/Rrs and inspiration 
Ers/Rrs  for seven breathing cycle for patient B10 from Cohort 2 for all PEEP levels. 
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Figure 5.9: (Top) Model-fitting between measured airway pressure and calculated airway 
pressure based on the lung elastance model for Patient S3 at PEEP = 10 cmH2O one 
breathing cycle. (Bottom) Model-fitting between measured airway flow and calculated airway 
flow for Patient S3 at PEEP = 10 cmH2O for one breathing cycle. 
 
5.4 Discussion 
 
The expiratory time constant K has shown a moderate correlation with Ers with R
2
= 0.568 in 
Cohort 1 and weak correlation with R
2
= 0.184 in Cohort 2, as shown in Figure 5.3. 
Comparatively, the correlation of K with the inspiration Ers /Rrs also shows a weak correlation 
of R
2
= 0.340 for Cohort 1 and a poor R
2
= 0.002 for Cohort 2, as depicted in Figure 5.4. These 
results contradict to the findings by Al Rawas et al. (2013) and the animal study by van 
Drunen et. al (2013) that showed K has good correlation with respiratory elastance estimated 
using inspiratory data. This result indicates that although K is defined as Ers/Rrs, it does not 
deliver the same result as those same values in inspiration because expiration and inspiration 
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must be considered separately when determining lung mechanics properties (Möller et al. 
2010). In particular, the difference in mechanics may be due to comparing the actively driven 
volume increase of inspiration with passive volume reduction in expiration.  
 
For the result shown in Figure 5.8, the calculated airway pressure using the inspiration single 
compartment lung model has resulted in a good fit with the measured airway pressure from 
the ventilator for data set S3 from Cohort 1, where the Median and IQR of the absolute 
percentage fitting error are 1.74 [0.79 - 2.79]%. However, a moderate fitting error is found in 
the calculated airway flow versus measured airway flow in this patient data set with Median 
and IQR of 8.60 [10.23-27.33]%. This error is due to noise that occurs early in the expiration 
flow cycle, as shown in Figure 5.8, thus resulting in poor model fitting at the beginning of 
expiration. However, a much better model fit occurred for the remaining expiration cycle. 
Thus, this result implies that by using the single compartment lung model, it follows the same 
trend as the measured data, but the K and Ers/Rrs values are different. 
 
Results for Ers can be seen in Figures 5.5 and 5.6, showing the parameter changes in response 
to PEEP change. Decreasing Ers which suggests overall lung recruitment with PEEP, whereas 
with increasing Ers, it shows that the lung becomes stiffer, thus no further recruitment 
happened in the lung, suggesting lung over-distension (Carvalho et al. 2007; Carvalho et al. 
2006; Suarez-Sipmann et al. 2007). It can be seen that from the beginning of the RM, at 
ZEEP, Ers is relatively high for all patients from Cohort 1. As PEEP rises, it is observed that 
Ers drops but increases again at PEEP = 25 cmH2O. This behaviour shows that recruitment 
occurs at lower to middle value of PEEP and that the lung is over-stretching when the PEEP 
increases to higher values. In contrast, it can be observed in Figure 5.6, that Ers increases as 
PEEP increases for Cohort 2. Hence, these results show that there is a possibility of over-
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stretching of healthy lung units in this cohort even the lung is ventilated at a lower PEEP 
levels and airway pressures due to the heterogeneity of ARDS across all patients (Stenqvist 
2003).  
 
These results show that monitoring patient-specific Ers during PEEP changes has the potential 
to be used in optimum PEEP titration for the ARDS patients (Chiew et al. 2012; Chiew et al. 
2011). It also shows that Cohort 2 may not be recruitable or already ventilated at too higher 
PEEP. Thus, if K had high positive correlation with Ers, as it did for Cohort 1, it could 
potentially be used to titrate PEEP, especially during partial ventilation support. 
 
Overall results in this study contradict the findings in the animal study by van Drunen et al. 
(2013). The study by van Drunen et al. (2013) showed that K has a similar trend with Ers in 
experimental ARDS animal trials (van Drunen et al. 2013). However, this study using human 
data showed otherwise. In particular, van Drunen et al.  (2013) had higher tidal volumes (Vt) 
of 10-12 mL/kg during MV. Higher Vt during ventilation allows more air to enter into the 
lung, thus allowing the respiratory system elastic properties to potentially be better identified. 
Equally, higher Vt will thus provide better flow data resolution during the expiration cycle. 
Compared to the animal study by van Drunen et al. (van Drunen et al. 2013), both human 
patient cohorts in this study have comparatively lower tidal volumes, limiting the data 
available during expiration. Note that these lower Vt values are well validated as a safe 
threshold (Brochard et al. 1998; Parsons et al. 2005; The Acute Respiratory Distress 
Syndrome Network 2000). Thus, for use in humans, controlled expiration would be required 
to get the best resolution and value of K that better reflects and correlates with Ers (Möller et 
al. 2010). 
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The discrepancy estimated parameter K is comparatively lower than in the studies conducted 
by Al Rawas et al. (Al-Rawas et al. 2013) and van Drunen et al. (van Drunen et al. 2013). 
One of the possibilities is that, the low variation, or ranges of parameter K, was not able to 
provide a platform for comparison between these two parameters of K and Ers. It can be seen 
that K has not shown significant changes as PEEP increases, as observed in Figures 5.5 and 
5.6 for both cohorts, especially for Cohort 2. In particular, Cohort 1 consists of 5 to 7 
different PEEP levels per patient, whereas Cohort 2 only consists of 3 relatively closely 
PEEP levels. Thus, there may be not enough PEEP variation in Cohort 2 in particular. In 
addition, single compartment model estimated respiratory elastance is a lumped parameter 
model and there may be several hidden variables and components that might be needed to 
better define respiratory system elastance (Bates 2009). 
 
In this study, a higher airway resistance in the lung can be seen in patients who suffer from 
Chronic Obstructive Pulmonary Disease (COPD), which is shown in Table 5.1. It can be seen 
from Table 5.1 that COPD patients from Cohort 1 (datasets S1, S4, S5, S9, S10) have higher 
resistance in the lung (Rrs) compared to other non-COPD patients (using a Wilcoxon rank 
sum test, p<0.005). The Median and Inter-Quartile Range [IQR] of Rrs for COPD is 11.00 
[6.68-17.22] cmH2O.s/L, while for non-COPD is 6.80 [5.66-7.86] cmH2O.s/L. This higher 
resistance in COPD patients is due to the effectively smaller airway diameter resulting from 
this condition that lead to a higher airway resistance when portions of airways are fully or 
partially collapsed in COPD (Damanhuri et al. 2014). This effect can be seen in COPD 
patient (S4) in Figure 5.7, where higher Rrs exists due to the obstructed airways at lower 
pressures and PEEP, as compared to the non-COPD patient (S3). These differences are also 
expected clinically.  
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Since K= Ers/Rrs, an increasing airway resistance would result in a low value of K. Significant 
variations in Rrs may thus lead to poor direct correlation between K and Ers (van Drunen et al. 
2013). Equally, these patients were found to have decreased K, as expected clinically, where 
a patient with COPD requires more time for expiration, which will lead to an increased 
expiratory time constant (~ 1/K) (Lourens et al. 2000).  
 
Cohort 1 and Cohort 2 are also clinically fundamentally different because of the difference in 
flow profiles used in MV. For some cases, K were relatively unchanged with PEEP, as shown 
in Figure 5.8 compared to the value of Ers or Ers/Rrs for dataset S1 and dataset B10. Similarly, 
the Median and Inter-Quartile Range [IQR] of K for Cohort 1 is 1.57 [1.33-1.99] 1/s, while 
Cohort 2 is a much tighter, more constant with 1.20 [1.13-1.34] 1/s across all PEEP levels. 
These results may be due to the fact that the same expiration flow pattern exists in both 
cohorts thus resulting in relatively constant values of K. In addition, it can also be seen from 
Figure 5.8 for S1 and dataset B10, that the trend of K does not follow either Ers or Ers/Rrs for 
both cohorts. This lack of correlation using the clinical data may also be a subject-specific 
response due to the increasing severity of ARDS collapsing airways within the lungs, thereby 
increasing the resistance of the conducting airways (Rrs) as mentioned previously in 
(Gattinoni & Pesenti 2005).  
 
Furthermore, this different result may also be due to the different protocols applied in these 
two studies (Al-Rawas et al. 2013; van Drunen et al. 2013). A better relationship and 
correlation between K and PEEP might be obtained by designing a clinical protocol where Vt 
is varied between low and high values at constant PEEP. Equally, controlled expiration cycle 
might be considered. In addition, variations in Rrs may lead to a lower correlation between K 
and Ers (van Drunen et al. 2013). Based on the results, as tabulated in Tables 5.1 and 5.2, it 
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was found that airway resistance varies across all patients. Thus, a larger study cohort would 
be needed to further validate this expiratory time constant model.  
 
Although K has shown a poor correlation for Cohort 2, it still delivered a good indication for 
COPD patients in Cohort 1 due to the higher airway resistance in the lung. Thus, potential 
application for K remains in diagnosing and provide further insight into lung condition in 
COPD patients. Furthermore, with specific ventilation profiles and a specific clinical 
protocol, K can be extended to determine real-time lung parameters using only expiration 
data.  
 
In particular, this application can be important in spontaneously breathing (SB) patients, 
where these patients have individual breathing effort that alters the lung mechanics on 
inspiration, but are similar in expiration (Grinnan & Truwit 2005). There are some techniques 
to measure the lung mechanics of SB patient such as the oesophageal balloon-catheter 
technique (Bates 2009). However, this technique is not suitable for clinical practice as it 
requires the balloon to be inserted into the patient and used in care, making it uncomfortable, 
invasive and interruptive of care for the patient (Khirani et al. 2010). Thus, the application of 
expiratory time constant in SB patients also warrants further investigation. 
 
5.5 Summary 
 
In summary, this research has shown that variations in lung resistance may lead to a lower 
direct correlation between inverse respiratory time constant, K and respiratory system 
elastance, Ers. The reason can be due to discrepancy of K and difference in clinical protocol 
that limits tidal volume safety threshold that can affect parameter identification process. 
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Thus, the ability of using K as a severity indicator or patients’ response to MV remains 
limited. Future investigation into this method is required before any implementation of the 
model parameter K should be considered, especially for SB patients where expiratory 
consistency can negate the effect of variable, patient-specific inspiratory efforts 
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CHAPTER 6 
Variability of Elastance in Pilot Clinical Data of ARDS Patients 
 
6.1 Introduction 
 
Experimental animal studies (Chiew 2013; Chiew et al. 2015; van Drunen et al. 2014) have 
shown that breath-to-breath model-based respiratory mechanics estimation can provide 
unique clinical information and insight into the condition. In particular, van Drunen et al. 
(van Drunen et al. 2014) and Chiew et al. (Chiew 2013) monitored the progressive changes in 
respiratory mechanics during oleic acid induced ARDS experimental models. They found that 
the respiratory elastance changes, as expected, from lower to higher values  when the lungs 
become more injured and stiffer with induced ARDS again, as expected (Carvalho et al. 
2007; Carvalho et al. 2006). These were the first results to observe these changes 
continuously, in real-time. Thus, monitoring the changes and variation of respiratory 
mechanics can be useful in the clinical situation, such that clinicians can intervene for 
treatment before the condition escalates. 
 
During mechanical ventilation, patients may exhibit spontaneous breathing even effort during 
fully controlled ventilation modes, when the patient is heavily sedated. Hence, ventilators are 
now incorporated with more advanced detection systems and protocols in an attempt to 
provide better patient ventilator interaction. However, these systems do not significantly 
reduce asynchronous patient-ventilator interactions. 
 
One of the ventilation modes commonly used in the Christchurch hospital is the synchronised 
intermittent mandatory ventilation mode (SIMV). This ventilation mode provides mandatory 
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breathing cycles to the patients, and it also provides a means for patient ventilator 
synchronisation by allowing patient triggering of the breath. It is thus a hybrid system mixing 
fully controlled and patient driven breathing support. With patient triggering and/ or 
spontaneous breathing effort, respiratory mechanics in these patients become more variable, 
particularly because the patient-specific inspiratory effort is not typically measured or known. 
This variability can then mask the respiratory mechanics based on the known ventilator 
inputs, so that the actual respiratory elastance trend cannot be identified accurately. Thus, this 
variability may affect management of MV guided by respiratory mechanics. Hence, 
understanding the underlying variability in respiratory mechanics will enable clinicians to 
understand when observed variability is within or outside expected natural variation, and thus 
in selecting optimal MV setting. 
 
This study thus aims to quantify the variability in model-based respiratory mechanics 
(elastance and resistance). A time-varying elastance model is used to estimate the respiratory 
mechanics of patients included in a prior prospective pilot clinical trial. The variability of 
dynamic elastance (Edrs) across all PEEP in MV patients was analysed. The goal is to provide 
a fundamental understanding of the patient-ventilator natural variability, leading to a 
definition of what level of variability is natural and what level constitutes a significant level 
of change in respiratory mechanics due to other factors. 
 
6.2 Methodology 
6.2.1 Patient Data and Analysis 
 
A clinical trial, Clinical Utilisation of Respiratory Elastance (CURE), is being carried out in 
the intensive care unit (ICU) of Christchurch, New Zealand. All patients are ventilated using 
84 
 
a Puritan Bennet PB840 ventilator (Covidien, Boulder, CO, USA) The airway pressure and 
flow curves for each patient were recorded and analysed using a time-varying elastance 
model proven on sedated, MV patients (Chiew et al. 2011).  
 
In this trial, several recruitment manoeuvres (RM) are performed by the attending clinician 
throughout the duration of MV. Prior to the study, written informed consent was obtained, 
and the trial and the use of the data were approved by the New Zealand South Regional 
Ethics Committee. The trial number is ACTRN12613001006730. Table 6.1 shows the patient 
details for those included in this study. 
 
Table 6.1: Characteristics of the patients 
 
Patient No. Gender Age Clinical Diagnostic 
1 Female 53 Faecal peritonitis 
2 Male 71 Cardiac surgery and contracted hospital acquired 
pneumonia 
3 Male 60 Pneumonia 
4 Male 36 Pneumonia 
5 Male 61 Pneumonia 
 
6.2.2 Inclusion and Exclusion Criteria 
 
The inclusion and exclusion criteria for CURE trial patients are defined: 
Inclusion Criteria 
1. Patient on Mechanical Ventilation. 
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2. Patient requiring invasive ventilation (Intubation or tracheotomy). 
3. Patients diagnosed with all degrees of ARDS severity (Partial Pressure of arterial 
blood gas oxygen per Fraction of Inspired Oxygen (PF Ratio) < 300 mmHg as per 
Berlin Definition (The ARDS Definition Task Force 2012), by intensive care 
clinicians. 
4. Arterial line in situ. 
 
Exclusion Criteria 
1. Patients who are likely to be discontinued from MV within 24 hours. 
2. Patients with age less than 16. 
3. Patients who have moderate or severe traumatic brain injury, and/or a measured 
intracranial pressure ≥ 20 cm H2O, 
4. Any medical condition associated with a clinical suspicion of raised intracranial 
pressure. 
5. Patients who have a high or spinal cord injury with loss of motor function. 
6. Patients who have significant weakness from any neurological disease. 
7. Patients who have acute severe pancreatitis and are expected to be ventilated for more 
than 10 days. 
8. Patients who have a pneumothorax. 
9. Patients who have asthma as the primary presenting condition. 
10. Patients who are moribund and/or not expected to survive for more than 72 hours. 
11. Patients whose care may be compromised if given increased sedation and/or muscle 
relaxants for the purpose of assessing lung recruitment. 
12. Lack of clinical equipoise by intensive care unit (ICU) medical staff managing the 
patient. 
86 
 
 
Termination criteria 
1. Mean arterial pressure (MAP) less than 60 mmHg for more than 5 minutes. 
2. Desaturation less than 88% for more than 5 minutes. 
3. Lack of clinical equipoise by the clinician E.g. When a patient has a low blood 
pressure and thought to be intolerant of PEEP changes. 
 
These criteria ensure a focus on the ARDS and respiratory failure patients most likely to 
benefit from patient-specific optimise MV therapy.  
 
6.2.3 Data Acquisition 
 
The CURE trial uses a software system (CURE Soft) developed using the JAVA platform 
(Szlavecz et al. 2014). CURE Soft applies the information of patient’s measured airway 
pressure and flow data to estimate respiratory mechanics parameters using an extended single 
compartment model that captures time-varying respiratory elastance model. This estimated, 
patient-specific model-based data is used to provide information on patient lung condition, 
disease progression and response to MV treatment (Chiew et al. 2011).  
 
6.2.4 Time Varying Elastance Model 
  
To investigate on the variability of elastance in ARDS patients, the time-varying elastance 
model is applied, which has been described in detail in Chapter 4. It is repeated here for 
clarity as: 
𝑃𝑎𝑤(𝑡) = 𝑅𝑟𝑠 ×  𝑄(𝑡) + 𝐸𝑑𝑟𝑠 × 𝑉(𝑡)  (6.1) 
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𝐸𝑑𝑟𝑠(𝑡) = 𝐸𝑐𝑎𝑔𝑒 + 𝐸𝑑𝑒𝑚𝑎𝑛𝑑 +  𝐸𝑙𝑢𝑛𝑔 
 
 (6.2) 
6.2.5 Data Analysis 
 
In this study, the area under the curve of Edrs (AUC Edrs) for every breathing cycle is 
estimated and analysed in each MV patient. A total of 97,944 breathing cycles in 3 
ventilation days were studied in this data set. The variability of AUC Edrs for each patient was 
quantified. For each patient, the median and interquartile range (IQR) of AUC Edrs were 
calculated. The median and IQR captures the centre and width of variability for a given 
patient. Robust coefficient of variation (RCV = median absolute deviation/median) of AUC 
Edrs was also calculated. A lower RCV indicates lower variability where as higher RCV 
indicates higher variability (Wysocki et al. 2006). 
  
In addition, the distribution and variability of AUC Edrs is also presented in cumulative 
distribution functions (CDF), which are useful as they show the entire distribution that is 
often summarised as median and IQR, providing further and complete insight into the 
distribution.  
 
6.3 Results 
6.3.1 Variability by ventilation days and PEEP 
 
Tables 6.2 and 6.3 show the summary of patients’ AUC Edrs distribution by ventilation day 
and by PEEP level. Due to the extensive number of data points per patient, only the first 3 
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days of the data were analysed for each patient. Figures 6.1 and 6.2 show the corresponding 
box-whiskers plot for each patient by day and by PEEP level. 
Table 6.2: The IQR of AUC Edrs and RCV for all five patients by ventilation days.  
 
Patient 
No. 
No. of 
breaths 
analysed 
AUC Edrs Median [IQR] (cmH2O.s/l) and RCV Total 
AUC Edrs Median 
[IQR] (cmH2O.s/l) 
and RCV 
Day 1 Day 2 Day 3 
1 5417 27.45 
[19.97-30.79] 
0.23 
7.41 
[2.38-16.36] 
1.04 
20.80 
[16.68-23.74] 
0.20 
18.25 
[9.98-23.57] 
0.44 
2 5857 8.39 
[3.49-15.69] 
0.62 
5.14 
[4.23-6.33] 
0.35 
3.96 
[3.49-4.55] 
0.29 
4.66 
[3.71-6.81 
0.26 
3 6582 14.76 
[14.02-15.48] 
0.21 
3.52 
[2.74-13.43] 
1.41 
18.70 
[16.83-19.76] 
0.11 
15.04 
[11.17-17.88] 
0.35 
4 7310 17.94 
[15.81-18.86] 
0.14 
17.46 
[16.83-18.03] 
0.05 
20.42 
[20.12-20.72] 
0.02 
18.40 
[17.22-20.34] 
0.10 
5 7482 20.50 
[18.06-22.36] 
0.13 
17.67 
[16.16-19.68] 
0.20 
20.15 
[19.66-20.79] 
0.04 
19.72 
[17.45-21.15] 
0.14 
 
Table 6.3: IQR of AUC Edrs and RCV for all five patients for all PEEP levels.  
 
Patient 
No. 
PEEP Levels (cmH2O) 
AUC Edrs Median [IQR] (cmH2O.s/l) and RCV 
1 PEEP 12 
14.85 
[10.25 - 16.83] 
0.26 
PEEP 16 
10.27 
[3.47– 19.94] 
0.85 
PEEP 19 
28.89 
[16.16-33.41] 
0.32 
PEEP 21 
28.63 
[35.86-37.85] 
0.15 
PEEP 23 
41.43 
[40.78-41.96] 
0.06 
2 PEEP 11 
11.97 
[6.21-18.13] 
0.43 
PEEP 13 
15.84 
[15.99-19.23] 
0.10 
PEEP 15 
4.35 
[3.56-6.91] 
0.76 
PEEP 19 
21.34 
[20.65-22.77] 
0.44 
PEEP 21 
23.67 
[23.34-25.54] 
0.06 
3 PEEP 10 
3.55 
[3.00-4.20] 
0.42 
PEEP 12 
2.77 
[2.32-3.35] 
0.49 
PEEP 15 
14.34 
[13.28-21.67] 
0.50 
PEEP 17 
15.93 
[6.56-24.53] 
0.57 
PEEP 19 
8.30 
[2.62-16.78] 
1.02 
4 PEEP 19 
21.53 
[18.93 – 22.55] 
0.13 
PEEP 21 
17.74 
[16.16-18.44] 
0.10 
PEEP 23 
18.25 
[17.29-19.28] 
0.09 
PEEP 26 
17.60 
[16.93-18.16] 
0.04 
PEEP 31 
23.30 
[22.83-24.64] 
0.05 
5 PEEP 13 
17.73 
[16.46-18.95] 
0.14 
PEEP 15 
17.35 
[14.95-20.89] 
0.22 
PEEP 17 
20.17 
[19.69-20.80] 
0.04 
PEEP 21 
22.23 
[20.73-23.00] 
0.08 
PEEP 22 
20.46 
[18.41-22.18] 
0.12 
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Figure 6.1: The distribution of AUC Edrs by ventilation days (Left) and by PEEP level (Right) 
for (Top) Patient 1. (Middle) Patient 2 (Bottom) Patient 3.  
-50
0
50
100
150
1 2 3
 Day
 A
U
C
 E
d
rs
,c
m
H
2
O
.s
/l
-50
0
50
100
11 12 13 14 15 16 17 18 19 21 23
 PEEP,cmH
2
O/l
 A
U
C
 E
d
rs
,c
m
H
2
O
.s
/l
-50
0
50
100
1 2 3
 Day
 A
U
C
 E
d
rs
,c
m
H
2
O
.s
/l
-50
0
50
100
11 12 13 14 15 16 17 18 19 20 21
 PEEP,cmH
2
O/l
 A
U
C
 E
d
rs
,c
m
H
2
O
.s
/l
-50
0
50
100
1 2 3
 Day
 A
U
C
 E
d
rs
,c
m
H
2
O
.s
/l
-50
0
50
100
10 11 12 13 14 15 16 17 18 19 21
 PEEP,cmH
2
O/l
 A
U
C
 E
d
rs
,c
m
H
2
O
.s
/l
90 
 
  
  
 
Figure 6.2: The distribution of AUC Edrs by ventilation days (Left) and by PEEP level (Right) 
for (Top) Patient 4 and (Bottom) Patient 5.  
 
Figures 6.3 and 6.4 show the airway pressure and AUC Edrs for Patients 1 and 3, where 
asynchrony events occurred during MV that resulted in a sudden change of AUC Edrs. In 
contrast, Figure 6.5 depicts an airway pressure and AUC Edrs for Patient 2 that shows a 
smooth and transient AUC Edrs with no trace of asynchrony events, which were not evident 
for patient and time period.  
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Figure 6.3: Airway pressure and AUC Edrs plots for Patient 1 containing asynchrony events 
which resulting with a sudden change of AUC Edrs indicating an asynchrony event has 
occurred 
 
 
 
Figure 6.4: Airway pressure and AUC Edrs plots for Patient 3 containing asynchrony events 
which resulting with a sudden change of AUC Edrs indicating an asynchrony event has 
occurred. 
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Figure 6.5: Airway pressure and AUC Edrs plots for Patient 2 which shows a constant airway 
pressure, resulting in a smooth and transient AUC Edrs. 
 
6.3.3 Cumulative distribution functions (CDF) of AUC Edrs by patients 
 
Figure 6.6 presents the cumulative distribution functions (CDF) of AUC Edrs across all PEEP 
levels for each patient. The CDFs of Patient 1 and 4 are shown in Figure 6.7, along with 
dashed lines indicating the 95% confidence intervals of AUC Edrs in each patient. 
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Figure 6.6: Cumulative distribution function (CDF) plot of AUC Edrs for all five patients at 
all PEEP levels. 
 
 
Figure 6.7: Cumulative distribution function (CDF) plot of AUC Edrs for Patient 1 and Patient 
4 at all PEEP levels. The dashed line show the 95% confidence interval (5th and 95th 
percentile) of AUC Edrs. 
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6.3.4 Breath to breath variability 
 
Breath to breath variability of AUC Edrs in Patients 1-3 are presented in a Poincare´ plot in 
Figures 6.8, 6.9 and 6.10, respectively. The Poincare´ plots show the distribution of AUC Edrs 
for all the three days. A linear line in each figure distinguishes the location of between AUC 
Edrs i and AUC Edrs i+1 relative to a 1:1 line defining their equality with no breath-breath 
variability. The width around the 1:1 line indicates breath-breath variability. 
 
   
Figure 6.8 Poincare´ breath to breath plot of AUC Edrs for Patient 1 by (Left) Day 1 (Middle) 
Day 2 (Right) Day 3. 
   
Figure 6.9: Poincare´ breath to breath plot of AUC Edrs for Patient 3 by (Left) Day 1 (Middle) 
Day 2 (Right) Day 3. 
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Figure 6.10: Poincare´ breath to breath plot of AUC Edrs for Patient 4 by (Left) Day 1 
(Middle) Day 2 (Right) Day 3.  
 
6.4 Discussions 
6.4.1 Variability by ventilation days and PEEP levels 
 
Tables 6.2 and 6.3 and the corresponding Figures 6.1 to 6.2 show the variability of AUC Edrs 
elastance with respect to mechanical ventilation days and PEEP. It can be clearly seen that 
the AUC Edrs varies at each day and PEEP level. Specifically, Patients 1 and 3 have higher 
RCV values of 1.04 and 1.41 on day 2 of ventilation, respectively. In contrast, Patient 4 has 
the least variability for all 3 days of ventilation with RCV ranges from 0.02 to 0.14.  
 
Furthermore, the AUC Edrs varies at PEEP level for each patient. Specifically, for Patient 1, 
the highest variability of elastance was observed at PEEP = 16 cmH2O with RCV value of 
0.85. Patient 2 also has a highest variability of elastance of RCV = 0.76 at PEEP = 15 cmH2O 
whereas Patient 3 has the highest RCV value of 1.02 at PEEP = 19 cmH2O. 
 
These variability changes were observed in ventilation days, as expected, due to recovery or 
worsening of the patient’s condition, and would likely be observed over clinically relevant, 
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but shorter time frame. However, not all patients exhibit similar behaviour compared to fully 
controlled ventilation modes with little patient-induced spontaneous breathing effort. Equally, 
the per-patient variability was equally wide in Figure 6.6-6.7 
 
6.4.2 Variability by patients 
 
Patients included in this study are all ventilated using SIMV volume control mode. During 
controlled ventilation, these patients exhibits variability in lung elastance, as shown in 
Figures 6.1 and 6.2. For example, Patients 1 and 3 have significantly higher variability due to 
the asynchronies that existed during synchronized intermittent mandatory ventilation (SIMV) 
mode, as shown in Figure 6.3 and 6.4, respectively. Asynchrony happens when the patient’s 
breathing effort is not synchronised with mechanical ventilation’s breathing support. 
However, it happens more frequently during non-invasive ventilation or partially assisted 
modes, where the patient is breathing spontaneously and the ventilator support is triggered by 
patient respiratory effort (Epstein 2011; Tobin et al. 2001; Vignaux et al. 2009). Hence, the 
choice of SIMV ventilated patients in this specific study. 
 
Asynchrony events can be regards as a significant mismatch between airway pressure and 
flow. Thus, this mismatch also affects the estimation of respiratory system mechanics, where 
the respiratory elastance can be under or overestimated compared to synchronised breathing 
cycles. In some cases, the estimated elastance can overshoot to a very high value as compared 
to normal airway pressure (Poole et al. 2014), as depicted in Figure 6.4 in Patient 3. This 
overshoot can be seen as the model capturing the external force generated from patient- 
specific and breath-specific spontaneous breathing efforts. Similarly, Patient 1 exhibits a SB 
effort although the patient was in fully sedated condition. This resulting with a constantly 
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asynchrony airway pressure as shown in Figure 6.3, that reduced the value of the elastance, 
limiting the calculation of accurate values of the lung elastance. 
 
Occasional AUC Edrs spikes that were observed in Patients 1 and 3 in Figures 6.3 and 6.4 
indicate that asynchronous events occur at any time throughout the ventilation period. This 
asynchrony events resulting with a variability in the respiratory elastance. Due to the 
asynchrony, the range of variability in AUC Edrs measurement in Patient 1 and 3 is higher 
with the RCV of 0.44 and 0.35, respectively. Thus, these results show that there is 
spontaneous variability and underlying variability. Due to the breath to breath variability in 
SB efforts, there is large variability due to the resulting  negative component of the 
respiratory elastance in Equation 6.2 (Chiew et al. 2015). This negative component of 
elastance will be further discussed in Chapter 7.   
 
In contrast, a smooth and transient AUC Edrs is observed in Patient 2 (Figure 6.5). 
Specifically, there is no pressure mismatch and thus no asynchrony events. Thus, these results 
clearly validate the idea that asynchrony events play a significant role in the observed, model-
based variability in breath-specific elastance in each patient.  
 
6.4.3 Distribution and variability of median AUC Edrs all patients at all PEEP 
 
From the CDF of all patients in Figure 6.6, it can be concluded the variability of AUC Edrs 
increases per patient. It can also be seen that Patient 1 is significantly different in median 
from all other patients (p<0.005) and significantly different in variability compared to all 
patients (p< 0.005). Examining the median and IQR of Patient 1, it shows that Patient 1 has 
higher ranger of AUC Edrs with 18.25 [9.98 - 23.57] cmH2O.s/l across all PEEP levels. For 
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example, the 95% confidence interval (5
th
 and 95
th
 percentile) value is significantly larger in 
Patient 1 than Patient 4 (p < 0.005) as in Figure 6.7, although both patients have almost 
similar median value of 18.25 cmH2O.s/l and 18.40 cmH2O.s/l respectively. In contrast, 
Patient 4 has a comparatively smaller range in the 5
th
 to 95
th
 range of AUC Edrs. This result is 
as expected, as Patient 1 exhibits a significant asynchrony compared to Patient 4. These 
results show that the central tendency of AUC Edrs is the same, but that the shape of the 
distribution can vary differently, patient-to-patient, clearly capturing patient-specific 
differences in condition and response to MV.  
 
6.4.4 Breath to breath variability  
 
Furthermore, Figures 6.8-6.10 show a Poincare´ plot for breath to breath analysis in Patients 
1, 3, and 4 for the 3 ventilation days. The patients are chosen based on the RCV value with 
Patients 1 and 3 having a higher variability, whereas, in contrast, Patient 4 has a much  lower 
variability. In the Poincare´ plot, the first AUC Edrs (AUC Edrs i) for the first breath (Poincare´ 
plot) is represented on the x-axis, and the AUC Edrs of the following breath (AUC Edrs i+1) is 
plotted on the y-axis. The Poincare´ plot also demonstrates that if the AUC Edrs i+1 is less than 
AUC Edrs i, this then indicates that the elastance is decreasing for the next breath. A consistent 
decreasing trend would indicate improving patient condition, shown in such figures as a bias 
around the 1:1 line. 
 
It can be seen from Figure 6.10 that the variation or Poincare´ plots for Patient 4 for all 3 days 
is almost a straight line, especially on Day 3 with RCV = 0.02. Although a few points exist 
outside the linear line, the majority of the points are within a 90% range that has much less 
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variability in elastance for Patient 4, which agrees with a small RCV value of 0.10, and 
indicates the clear per-patient differences that may be seen.  
 
In contrasts, the Poincare´ plots for Patient 3 in Figure 6.9 demonstrate that the distribution of 
data are scattered away from the linear line. This elucidates the breath to breath variability of 
elastance in Patient 3 is higher with a RCV value of 0.35. Similarly, the same results apply to 
Patient 1, with breath to breath variability of data points are scattered away from the liner 
line. The much higher variability in AUC Edrs in Patients 1 and 3 is expected, due to the much 
more frequent, stronger and more variable SB effort produced by both patients. This outcome 
can be seen from Figures 6.8 and 6.9, where there exists data points of AUC Edrs in the 
negative regions, which further validates the idea the negative values of elastance that 
decrease the overall values of Edrs and, in this case, results in negative values of Edrs(t) and far 
greater variability in overall respiratory elastance. The investigation of the negative elastance 
SB effort will be discussed in detail in Chapter 7. 
 
Specifically, for Patient 1, on day 2, some of the AUC Edrs data points lie above the linear line 
as shown in Figure 6.8. This implies that AUC Edrs i is greater than AUC Edrs i+1 which 
elucidates that the lung condition is getting worse for every consequence breaths. However, 
on day 3, some of the AUC Edrs points lie under the linear line which show that the AUC Edrs i 
is lesser than AUC Edrs i+1. Thus, this result indicates that the lung condition of Patient 1 has 
improved.  
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6.5 Summary 
 
In this chapter, this research quantified the variability identified and estimated respiratory 
mechanics properties used to potentially guide ventilation care in sedated patients. With this 
information, it could guide ventilation in PEEP titration to the optimal elastance which could 
protect the lung from over-distension condition. Clinically, results on the variability of 
elastance have shown significant implications for managing PEEP titration for MV patients. 
However, due to patient-specific breathing effort, it produced a negative elastance, resulting 
with a variability in elastance. The asynchrony is also known as another factor that 
contributes to the variability in elastance. Thus, Chapter 8 will then introduce a model-based 
that could re-construct the pressure that has been reduced due to the asynchrony problem, and 
improving the estimation of the accurate value of the lung elastance. 
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CHAPTER 7 
Lung Elastance Monitoring for Spontaneously Breathing Patient 
 
7.1 Introduction 
 
Most of the lung models that have been developed are only effective for fully sedated patients 
(Brochard et al. 2012; Hickling 1998a; Sundaresan et al. 2009). They cannot be applied 
directly to the spontaneously breathing (SB) patients due to the different lung mechanisms 
between fully sedated and SB patient. In particular, they add input energy in the form of 
negative pressure due to their muscles opening the chest cavity and allowing air to enter. This 
SB input cannot be accurately modelled at this time and cannot be predicted accurately. 
However, because there are a significant number of patients on mechanical ventilation (MV) 
who have some level of SB effort, it will be valuable to develop and integrate a metric that 
allows analysis of the true respiratory mechanics in SB patients (Kallet & Branson 2007). 
 
SB patients have individual breathing efforts aside from the ventilator support (Grinnan & 
Truwit 2005). These efforts modify the measurable airway pressure and/or flow waveforms, 
which can significantly alter the identified lung mechanics. The main obstacle is to be able to 
find a metric that able to detect the presence of the SB effort and to then identify or estimate 
the level of SB effort exerted by the patient. A suitable method might thus quantify the effort 
from sudden or unnatural changes in the pressure or flow waveforms, or may require direct 
measurement of the SB patient’s muscular movement, as seen in invasive measurements in 
the NAVA system (Chiew et al. 2013).  
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There are some techniques that have been applied to directly measure or attempt to monitor 
the breathing effort made by SB patients. One of the most well-known methods is the 
balloon-catheter technique used to measure the oesophageal pressure, which is the surrogate 
of the pleural pressure (Ppl) (Khirani et al. 2010; Talmor et al. 2008). However, this technique 
is not suitable for clinical practise as it requires the balloon to be inserted into the patient and 
used to interrupt breathing. It is thus a very intrusive measurement and not feasible for 
regular clinical use despite its potential to accurately measure SB effort and thus potentially 
optimise and guide MV for SB patients with ARDS (Guérin & Richard 2012). 
 
Another approach to measure the SB effort is by monitoring the electrical activity of the 
diaphragm (Eadi) of the ventilated patient. This measurement captures muscle activity as a 
surrogate for this SB input. It can thus provide a better monitoring of patient-ventilator 
synchrony in SB patients (Moorhead et al. 2013; Piquilloud et al. 2011). However, there is a 
potential of tidal volume leak in this, also invasive, measurement that can affect the 
measurement of the SB effort (Moorhead et al. 2013). In addition, this measurement requires 
an additional expensive sensor that must be very accurately positioned.   
 
In Chapter 6, it was mentioned that one of the reasons of the variability is due to the negative 
elastance effectively caused by un-modelled the SB effort. This negative elastance is 
hypothesised to be due to a positive lung volume intake through the SB effort induced 
negative pressure in the lung compartment (Chiew et al. 2015). Thus, in this chapter, a non-
invasive model-based method, based on time varying respiratory system elastance, is 
implemented to review the distribution of negative elastance in SB patients to quantify its 
potential level and impact.  
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7.2 Methodology 
7.2.1 Patient Data 
 
In this study, this model is assessed using clinical data from Clinical Utilisation of 
Respiratory Elastance (CURE) study patients. The associated protocols have been described 
in detail in Chapter 6, along with demographics and ethics approval details, so they are not 
covered here.  
 
7.2.2 Spontaneously Breathing Respiratory Model 
 
The model is based on the time varying elastance model described in details in Chapter 4, and 
repeated here for clarity as:  
𝑃𝑎𝑤(𝑡) = 𝑅𝑟𝑠 ×  𝑄(𝑡) + 𝐸𝑑𝑟𝑠 × 𝑉(𝑡) 
 
 (7.1) 
𝐸𝑑𝑟𝑠(𝑡) = 𝐸𝑐𝑎𝑔𝑒 + 𝐸𝑑𝑒𝑚𝑎𝑛𝑑 +  𝐸𝑙𝑢𝑛𝑔 
 
 (7.2) 
During inspiration, Q is positive leading to an increasing integrated volume (V). In SB 
patients, Edemand represents the change in elastance due to patient-specific SB effort. Thus, 
this elastance, Edemand, has a negative value due to the diaphragm contracting and the 
intercostal muscles that move the rib cage upwards, which both increase the volume of the 
chest compartment. This increase, creates a negative pressure gradient that draws air into the 
lungs and is the sole mechanics of breathing in healthy individuals. As patient demand aids 
the breathing effort, the effective overall pressure based on Equation 7.1, is therefore 
reduced, leading to a reduced identified value of elastance. 
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7.3 Data analysis 
 
In this study, the area under the curve (AUC) for the time-varying elastance, Edrs, is estimated 
for each SB patient. The results are reported as median and interquartile range (IQR) for 
continuous data with CURE collecting a total of 82 hours.  
 
7.4 Results 
 
Figures 7.1-7.3 present the distribution of positive and negative AUC Edrs for all 5 patients. 
For the same patients, the 5
th
, 25
th
, 59
th
, 75
th
, and 95
th
 percentiles of the negative and positive 
AUC Edrs data are also tabulated in Table 7.1. Separating the positive and negative values 
into two plots allows easier quantification at these elastance values. A negative AUC 
indicates the entire elastance Edrs profile was less than 0. This behaviour occurs when as seen 
in Figure 7.4. The vast majority have AUC Edrs > 0 as expected. 
 
Table 7.1: Negative and positive AUC Edrs (5th, 25th, 59th, 75th, 95th percentile) for all 
5 patients. 
 
Patient Negative AUC Edrs 
 
Positive AUC Edrs 
 
 5
th
 25
th
 50
th
 75
th
 95th 5th 25
th
 50
th
 75
th
 95th 
1 -7.76 -3.03 -1.65 -0.70 -0.18 2.51 12.15 18.94 23.85 31.63 
2 -16.81 -3.89 -2.08 -0.92 -0.23 2.91 3.73 4.67 6.85 16.70 
3 -11.52 -1.76 -0.66 -0.19 -0.03 2.40 10.85 14.99 17.90 21.15 
4 -6.08 -3.22 -2.27 -0.69 -0.16 14.87 17.20 18.36 20.34 21.43 
5 -6.02 -2.27 -0.98 -0.47 -0.19 14.50 17.47 19.73 21.16 24.57 
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Figure 7.1: The distribution of positive (upper) and negative (lower) values of AUC Edrs by 
hour for (Top) Patient 1 and (Bottom) Patient 2. The positive and negative values are 
combined for the entire distribution.  
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Figure 7.2: The distribution of positive (upper) and negative (lower) values of AUC Edrs by 
hour for (Top) Patient 3 and (Bottom) Patient 4. The positive and negative values are 
combined for the entire distribution.  
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Figure 7.3: The distribution of positive (upper) and negative (lower) values of AUC Edrs by 
hour for Patient 5. The positive and negative values are combined for the entire distribution. 
 
 
Figure 7.4: The Edrs for a single breath for Patient 3 that shows the negative and positive 
values of Edrs. 
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7.5 Discussion 
 
In this study, it was observed that all 5 patients had some negative AUC Edrs, as shown in 
Figures 7.1-7.3. Negative elastance occurs when negative pressure is generated in the 
patient’s pleural space causing air volume to enter the lung. As pleural pressure decreases due 
to patient’s inspiratory demand, the airway pressure or flow changes. More specifically, Edrs 
will be less than zero when patient breathing demand is high at the beginning of inspiration, 
and will gradually decrease in magnitude as patient demand decreases during the breath. A 
negative AUC of Edrs occurs when this negative area outweighs the positive area when Edrs < 
0, as seen in Figure 7.4. 
 
Table 7.1 shows the negative and positive data of the AUC Edrs. It can be seen that that the 
95
th
 percentile of the positive AUC Edrs was above 25 cmH2O.s/l for Patient 1, although this 
patient exhibits a negative elastance due to SB efforts. ARDS patients have been shown to 
have higher respiratory elastance with Edrs > 25 cmH2O/l (The ARDS Definition Task Force 
2012). These results show that, the proposed AUC Edrs metric is able to capture mechanics 
similar to those observed in ARDS patients when fully sedated in MV, giving confidence of 
the clinical relevance of the AUC Edrs value used here. For the other patients, the 95
th
 
percentile of AUC Edrs were below than 25 cmH2O/l, which suggests that the patients in this 
SB study were more compliant than that of fully sedated ARDS patients lungs, as might be 
expected for SB patients with less intrusive ventilation (Chiew et al. 2014). 
 
The AUC Edrs for SB patient is dependent on the initial pleural pressure or the magnitude of 
negative Edemand. Thus, a lower AUC Edrs may indicate that a patient has comparatively higher 
individual breathing effort than others, and obviously more than a sedated patient. Thus, the 
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AUC Edrs metric is able to uniquely capture the information of SB patients without the use of 
invasive protocols.  
 
Specifically, for Patient 4, the negative AUC Edrs occurred only at 3 and 15 hours. The 
existence of the negative elastance might be due to the ventilator setting of the patient during 
this time when the ventilation mode was switched to an assisted spontaneous breathing 
(ASB) mode. As expected, Patients 1 and 3 have the largest distribution of negative AUC Edrs 
values due to the larger number of asynchrony events they experienced, which were 
discussed previously in Chapter 6.   
 
This model can thus be generalised over the SB and sedated MV patients based on the Edrs 
value, where negative Edrs relates to SB effort and reduced AUC Edrs can also indicate SB 
efforts. Thus, the Edrs value and trajectory can be used as a simple, real-time indicator to 
assess patient-specific disease state and response to MV specifically for SB patients 
monitoring.  
 
7.6 Summary 
 
This proposed spontaneous breathing model monitoring is able to capture unique dynamic 
respiratory mechanics specifically for spontaneously breathing patient without additional 
measuring equipment or interruption of care. Thus, with this metric, it is able to guide 
clinicians in setting the optimal mode of the ventilation that meet the patient’s demand. 
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CHAPTER 8 
Processing of Pressure Waves for Respiratory Mechanics 
Estimation by Spontaneously Breathing Efforts 
 
8.1 Introduction 
 
Estimation of respiratory mechanics can enable individualised mechanical ventilation (MV) 
therapy (Lauzon & Bates 1991; Lucangelo et al. 2007). However, most of the mathematical 
lung models developed are only suitable for fully sedated patients (Brochard et al. 2012; 
Sundaresan et al. 2011a; Talmor et al. 2008; Talmor et al. 2006). Others are also too complex 
for use as a bedside application (Donovan 2011; Kitaoka et al. 2007; Tawhai & Bates 2011; 
Tawhai et al. 2004).  
 
Current bedside respiratory models are limited and cannot be applied directly to 
spontaneously breathing (SB) patients. These patients exhibit modified airway pressure and 
flow profiles due to their own variable inspiratory effort (Grinnan & Truwit 2005). These 
modified airway pressure and flow are variable and heterogeneous in level and appearance, 
rendering the underlying pulmonary mechanics of SB patients difficult to identify correctly 
from measured airway pressure and flow data alone. However, due to the significant number 
of patients on MV who demonstrate intermittent SB effort, as seen in Chapter 6 and 7, it is 
essential to have a mathematical model that can be applied to analyse respiratory system 
mechanics in SB patients. 
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In particular, this specific problem arises when a patient exhibits SB effort on top of a 
ventilator supported breathing cycle. This phenomenon is known as reverse triggering 
(Akoumianaki et al. 2013), which results in a consistent occurrence of ‘entrainment’ in 
observed airway pressure waveforms. This ‘entrainment’ can be denoted as an M-wave due 
to its shape, as shown in Figure 8.1. This M-wave pressure curve creates a significant 
problem in identifying accurate values for respiratory system elastance and airway resistance 
(Chiew et al. 2011). Hence, it is important to have a method to overcome the impact of these 
M-waves and provide a more consistent estimation of the underlying and SB unaffected 
respiratory system mechanics for clinical monitoring.  
 
  
Figure 8.1: Left: Normal airway pressure Right: M-wave airway pressure.  
 
During volume controlled ventilation, if the patient breaths on top of a ventilation support, 
the patient’s breath-specific inspiratory effort induces a reduction in airway pressure that the 
model sees as reduced respiratory elastance due to the same volume being delivered for less 
pressure (Alencar et al. 2002; Chiew et al. 2015). This M-wave pressure curve creates a 
significant problem in identifying accurate values for the true, underlying respiratory system 
0 0.5 1 1.5 2
14
16
18
20
22
24
26
28
30
 Time, s
 P
re
s
s
u
re
, 
c
m
H
2
O
 
 
0 0.5 1 1.5 2
14
16
18
20
22
24
26
28
30
 Time, s
 P
re
s
s
u
re
, 
c
m
H
2
O
 
 
112 
 
elastance and airway resistance as this input is not known or modelled (Schranz et al. 2012b). 
Hence, it is important to have a method to overcome the impact of these M-waves and 
provide a more consistent estimation of the underlying respiratory system mechanics for 
clinical monitoring especially for SB patients.  
 
In addition to reducing the impact of M-waves, it is essential to have a metric that detects the 
presence of these M-waves and quantifies how much breathing effort is exerted by the patient 
during reverse triggering. Currently, there are no metrics that quantify SB effort during MV 
without using highly invasive oesophageal pressure catheters (Benditt 2005; Khirani et al. 
2010; Talmor et al. 2006).  
 
Clinically, these SB efforts need to be assessed to determine if the MV mode needs to be 
adjusted or adapted to patient breathing effort for better patient-ventilator interaction 
(Piquilloud et al. 2011). Thus, a metric that can act as a surrogate of SB effort and its 
contribution in altering the airway pressure waveform is required, clinically, as well as for 
model-based methods. An automated, model-based approach would also offer first ever 
quantification of the incidence and severity of SB efforts and asynchrony. 
 
In this chapter, a model-based method is used to reconstruct the M-wave affected airway 
pressure curve. This method hypothesizes that the true, underlying respiratory mechanics do 
not change significantly breath to breath at a given pressure level, as is already evident in 
sedated patients without SB efforts. This method aims to provide a more consistent 
respiratory mechanics monitoring through reconstruction of the ‘actual’ airway pressure. 
Using the reconstructed pressure and the M-wave affect pressure, metric to identify breath 
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and patient-specific effort is developed. This information is capable of providing new clinical 
insight to patient condition and response to treatment.  
 
8.2 Methodology 
8.2.1 Clinical data 
 
Data recorded from a clinical trial carried out in the intensive care unit (ICU) of Christchurch, 
New Zealand were used in this study, with the data acquisition process detailed in Chapter 6 
(Szlavecz et al. 2014).  
 
Table 8.1: Characteristics of the patients. 
 
Patient No. Gender Age Clinical Diagnostic 
    
1 Female 53 Faecal peritonitis 
2 Male 71 Cardiac surgery and contracted hospital acquired 
pneumonia 
3 Male 60 Pneumonia 
4 Male 36 Pneumonia 
5 Male 61 Pneumonia 
 
8.2.2 Time Varying Respiratory Elastance Model 
 
Model-based time-varying elastance is identified breath-to-breath using a single compartment 
lung model which has been described in detail in Chapter 4 in Equations 4.1 and 4.2 (Chiew 
et al. 2015; Lauzon & Bates 1991). These two equations are 
𝑃𝑎𝑤(𝑡) = 𝑅𝑟𝑠𝑄(𝑡) +  𝐸𝑟𝑠(𝑡)𝑉(𝑡) +  𝑃0  (8.1) 
 
∫ 𝑃𝑎𝑤 (𝑡)𝑑𝑡 = 𝑅𝑟𝑠 ∫ 𝑄(𝑡)𝑑𝑡 +  𝐸𝑟𝑠(𝑡) ∫ 𝑉(𝑡) 𝑑𝑡 +  ∫ 𝑃0  𝑑𝑡  (8.2) 
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Then, an average lung resistance (Rave) is calculated based on the value of Rrs for every PEEP 
level and it is substituted into Equation 7.3 where the dynamic elastance, Edrs is defined as a 
time-varying lung elastance and identified using (van Drunen et al. 2014): 
𝐸𝑑𝑟𝑠(𝑡) =  
𝑃𝑎𝑤(𝑡) −  𝑃0 − (𝑅𝑎𝑣𝑒𝑄(𝑡))
𝑉(𝑡)
 
 
 (8.3) 
 
For each breathing cycle, the area under the curve of Edrs (AUC Edrs) is then calculated as a 
surrogate of respiratory elastance (Chiew et al. 2015). 
 
8.2.3 Pressure Reconstruction Method  
 
Patients with the ability to breathe spontaneously, even if sedated, create abnormal airway 
pressure waveforms shaped like an “M” (Akoumianaki et al. 2013), as shown in Figure 8.2. 
The lower pressures and M-wave curves result in a significantly lower identified elastance 
since pressure is reduced by patient-specific induced inspiratory effort for the same volume 
delivered. In Figure 8.2, the respiratory system elastance and airway resistance for the normal 
airway pressure (left) are 25.85 cmH2O/l and 10.22 cmH2O·s/l, respectively. In contrast, 
direct application of Equation 8.1 using the M-wave airway pressure results in an elastance of 
13.70 cmH2O/l and a resistance of 12.91 cmH2O.s/l. Thus, to provide a more consistent 
clinically useful result, to identify the true, underlying mechanics, unaffected by patient-
specific inspiratory effort, a simple pressure wave reconstruction method to remove or reduce 
the impact of SB efforts or measured airway pressure waveforms is necessary. 
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Figure 8.2: Left: Normal airway pressure provides well-fit model. Right: M-wave causing 
poor model fit.  
 
The proposed pressure reconstruction method identifies and compares both the maximum 
peaks of the inspiration pressure waveform (Figure 8.3). Point b1 is defined as five data 
points after the end of inspiration, while a1 is defined as five data points after point b1. These 
two points will be used as a reference point to determine the gradient of the airway pressure 
during expiration (Figure 8.3b). A line that connects a1 and point b1 is extrapolated to point 
c1, which has the same pressure value as the maximum pressure for the breath (c2 on Figure 
8.3c). Point c1 and the maximum peak c2 are connected by a line that connects the peak and 
end inspiratory gradient. Figure 8.3 shows the sequence of how the airway pressure 
reconstruction is performed. This method is also applicable when the peak pressure occurs 
after the asynchrony event, and is the second peak. In that case, the process is reversed. 
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(a) 
 
(b) 
 
(c) 
 
(d) 
 
 
Figure 8.3: The steps on the reconstruction process (a) The M-wave airway pressure. (b) The 
maximum peak, point a1 and point b1 are identified. (c) The slope of  point a1 and point b1 is 
extrapolated until point c1, which has the same pressure value as the maximum peak. (d) The 
estimated final result of the reconstruction airway pressure. 
 
 
8.2.4 Assessing Spontaneous Breathing Effort  
 
The overall goal of the reconstruction method is to reduce the pressure drop created by the 
patient-specific inspiratory effort that reduces the measured airway pressure. The enclosed 
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area, shown in Figure 8.4 (A2), is hypothesized to be a surrogate of patient-specific 
inspiratory effort that could be used to assess the strength of SB efforts.  
 
 
Figure 8.4: The area of the missing pressure, A2 is shaded with dark colour.  
 
The area of the M-wave over PEEP pressure is identified as A1 and it has reduced pressure 
compared to the reconstructed curve, resulting in a lower overall time varying elastance 
(AUC Edrs). However, by adding the area of a missing pressure (A2), the effect of the patient-
specific breathing effort is reduced, leading to a higher value of identified elastance. Thus, 
the percentage of spontaneous breathing effort can be defined: 
SB effort =
A2
A1 +  A2
 × 100% 
  
 (8.4) 
where it is important to note that A1 and A2 are independent of the PEEP level, which is 
15cmH2O in Figure 8.4. 
 
Furthermore, from Equation 8.3, an accurate value of Edrs can be estimated and defined:  
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𝑃𝐴1 + 𝑃𝐴2 −  𝑅𝑎𝑣𝑒𝑄(𝑡)
𝑉(𝑡)
=  𝐸𝑑𝑟𝑠_𝑟𝑒𝑎𝑙 
 (8.5) 
 
Where 𝑃𝐴1is the unreconstructed pressure, 𝑃𝐴2 is the pressure of the missing A2, and Edrs_real is 
the accurate value of the respiratory elastance after the reconstruction process. If the 
resistance is constant and the volume controlled ventilation mode is set to have a fixed flow 
pattern to deliver set tidal volume, then 𝑅𝑎𝑣𝑒𝑄(𝑡) can be assumed constant. Due to the SB 
breathing effort, Edrs is lower compared to normal breathing pressure, as only the 𝑃𝐴1 
component of pressure is present, yielding: 
𝑃𝐴1
𝑉(𝑡)
−  
𝑅𝑎𝑣𝑒𝑄(𝑡)
𝑉(𝑡)
=  𝐸𝑑𝑟𝑠_𝑙𝑜𝑤 
 (8.6) 
 
Edrs is expected to be lower when there is additional unmodelled and unmeasurable energy 
input from the patient due to their SB effort, to add air volume. Therefore, it takes less 
pressure from the ventilator to achieve the target volume. Accounting for this difference 
using 𝑃𝐴2 yields: 
(
𝑃𝐴1
𝑉(𝑡)
+
𝑃𝐴2
𝑉(𝑡)
) −  
𝑅𝑎𝑣𝑒𝑄(𝑡)
𝑉(𝑡)
=  𝐸𝑑𝑟𝑠_𝑙𝑜𝑤 +  𝐸𝑑𝑟𝑠_𝑆𝐵 
 (8.7) 
 
If the term 𝑅𝑎𝑣𝑒𝑄(𝑡) is assumed to be constant, Edrs relies heavily on the change of pressure. 
Hence, the elastance difference due to the SB effort can be defined: 
𝐸𝑑𝑟𝑠_𝑆𝐵 =  
𝑃𝐴2
𝑉(𝑡)
 
 (8.8) 
 
Given that V(t) is the same in both cases, it can be said that:  
𝑃𝐴2 ∝  𝐸𝑑𝑟𝑠_𝑆𝐵 
 
 (8.9) 
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Therefore, 𝐸𝑑𝑟𝑠_𝑆𝐵is a good surrogate of SB effort specific to a particular breath and patient. 
This approach thus creates a unique, new and non-invasive estimate of SB effort with no 
additional measurement or intervention required.  
 
Finally, the work done by breathing can be determined using: 
𝑊𝑂𝐵 = ∫ 𝑃𝐴1(𝑉)𝑑𝑉
Δ𝑉
 
 (8.10) 
 
Equation 8.10 can then be modified to utilise the lines shown in Figure 8.5, yielding:  
% 𝑜𝑓 𝑊𝑂𝐵𝑆𝐵 = ∫
𝑃𝐴2
𝑃𝐴1 +  𝑃𝐴2
(𝑉)𝑑𝑉
Δ𝑉
× 100% 
 (8.11) 
 
8.2.5 Data analysis 
 
In this study, the Edrs for every breathing cycle of each patient is normalised and the AUC Edrs 
is calculated both with and without pressure reconstruction, to prove the concept for different 
PEEP levels in 5 patients for all 275 breathing cycles recorded. It is hypothesized that the true 
underlying mechanics change little, if at all, from breath-to-breath at a given PEEP level, 
matching results from sedated patients with no SB effort (Chiew et al. 2011; Chiew et al. 
2015). Intermittent and variable SB efforts thus add variability to identified elastance and 
mechanics. The variability in AUC Edrs for the reconstruction method was also determined 
and compared with the AUC Edrs for the unreconstructed pressure by using the robust 
coefficient of variation (RCV = median absolute deviation/median), to compare the resulting 
variability in each metric over several breaths.  
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8.3 Results 
 
Figure 8.6 shows the reconstructed airway pressure and the calculated AUC Edrs values for 
Patient 1 at PEEP of 15 cmH2O. Figure 8.6 shows that many observed airway pressure waves 
were the typical airway pressure waveform expected from fully sedated patients. However, 
there are some breaths that exhibit M-wave characteristics. The highest AUC Edrs values were 
associated with the least effected pressure waves.  Ers and Rave were calculated to determine 
the AUC Edrs using Equation 8.3. The Edrs curves are shown in Figure 8.7 for two of these 
breaths, one M-wave and one normal, and the difference in area under the Edrs curve between 
the normal wave and M-wave can be observed. 
 
 
Figure 8.5: Top: The unreconstructed with M-wave airway pressure and reconstructed airway 
pressure for Patient 1 PEEP = 15 cmH2O. Bottom: The AUC Edrs for both airway pressures at 
PEEP = 15 cmH2O for Patient 1. 
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Figure 8.6: Example of airway pressure curve and Edrs curves for Patient 1 Top: The M-wave 
and normal pressure curve at PEEP = 15 cmH2O. Bottom The Edrs curves for the M-wave and 
reconstructed M-wave and normal wave breaths normalized to the same inspiratory time at 
PEEP = 15 cmH2O. Reconstruction improves estimate towards unaffected breath. 
 
Figure 8.7 illustrates the reconstructed pressure volume (PV) curves for Patient 1 at a PEEP 
of 15 cmH2O that captures the behaviour exhibited in the breath that was free from SB 
efforts. Figures 8.8 and 8.9 show unreconstructed airway pressure, reconstructed airway 
pressure, and the comparison of AUC Edrs for each PEEP level for Patients 1 and 4. 
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Reconstruction inevitably leads to higher modelled pressure and higher elastance, and thus, in 
this case, less variability in the calculated AUC Edrs. Figures 8.8 and 8.9 also show the 
surrogate inspiratory breathing effort based on Equation 8.4.  
 
Table 8.2 summarises the calculated AUC Edrs and breathing effort for all 275 breathing 
cycles. A total of 81 cycles (~30%) were affected with the M-waves across all patients. The 
results between unreconstructed pressure and reconstructed pressure were compared. The 
RCV is calculated and compared for each PEEP level per patient and tabulated in Table 8.2. 
Figure 8.10 depicts the distribution plot for % of WOB against % of SB effort across all 
patients at all PEEP levels. 
 
 
Figure 8.7: The PV curve of Patient 1 at PEEP 15 cmH2O for M-wave (blue line) and 
reconstructed curves (red line). 
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Figure 8.8: The AUC Edrs and for M-wave and reconstructed airway pressure and the 
surrogate inspiratory effort that added by the Patient 1 using reconstruction method for Left: 
PEEP = 15 cmH2O and Right: PEEP = 17 cmH2O. 
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Figure 8.9: The AUC Edrs and for unreconstructed and reconstructed airway pressure, and the 
surrogate inspiratory effort that added by the Patient 4 using reconstruction method for Left: 
PEEP = 19 cmH2O and Right: PEEP = 22 cmH2O. 
 
 
Figure 8.10: Plot of % of WOB against % SB effort across all patient breaths at all PEEP 
levels. 
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Table 8.2: The AUC Edrs and RCV for unreconstructed M-wave and reconstructed M-wave, and the percentage of SB surrogate for 5 
patients at different PEEP levels 
 
Patient PEEP 
(cmH2O) 
Breathing 
cycle 
M-wave 
cycle 
Unreconstructed 
AUC 
Edrs(cmH2O·s/l) 
Reconstructed 
method AUC Edrs 
(cmH2O·s/l) 
SB Effort 
(%) 
WOB 
(%) 
RCV for 
AUC Edrs 
(M-wave) 
RCV for  
AUC Edrs 
(Reconstructed) 
1 15 29 15 21.99 
[18.37-24.06] 
22.95 
[21.38-24.09] 
0.00 
[0.00-11.38] 
0.06 
[0.00-6.60] 
0.14 0.08 
 17 33 19 20.69 
[19.10-24.28] 
23.95 
[22.71-24.99] 
10.95 
[0.00-14.79] 
4.56 
[0.01-7.74] 
0.14 0.05 
2 15 30 7 16.73 
[16.38-17.06] 
16.95 
[16.69-17.24] 
1.13 
[0.98-1.43] 
1.53 
[0.75-1.78] 
0.02 0.01 
 17 18 8 22.01 
[21.08-23.49]] 
22.48 
[20.84-23.70] 
0.76 
[0.00-1.22] 
0.75 
[0.10-1.09] 
0.07 0.07 
3 13 32 5 18.88 
[18.05-19.59] 
19.16 
[18.36-19.92] 
0.62 
[0.22-0.92] 
0.43 
[0.25-0.62] 
0.05 0.04 
 14 31 5 15.24 
[15.00-15.57] 
15.56 
[15.28-15.82] 
0.00 
[0.00-0.24] 
0.33 
[0.10-0.56] 
0.03 0.03 
4 19 29 4 22.80 
[22.57-23.11] 
22.80 
[22.61-23.12] 
0.00 
[0.00-0.14] 
0.33 
[0.19-0.41] 
0.03 0.02 
 22 31 6 15.56 
[14.77-16.20] 
15.89 
[15.02-16.24] 
0.00 
[0.00-0.12] 
0.22 
[0.08-0.39] 
0.04 0.04 
5 17 21 8 19.98 
[18.98-20.31] 
20.22 
[19.22-20.61] 
0.66 
[0.41-0.77] 
0.76 
[0.53-1.12] 
0.05 0.05 
 21 21 4 22.18 
[22.02 – 22.82] 
22.77 
[22.51-23.25] 
1.15 
[0.91-1.75] 
1.31 
[1.00-1.71] 
0.03 0.03 
Median 
[IQR] 
   19.21 
[16.30-22.47] 
20.41 
[16.68-22.81] 
0.45 
[0.00-1.15] 
0.54 
[0.18-1.21] 
0.05 
[0.03-0.07] 
0.04 
[0.03-0.05] 
126 
 
8.4 Discussion 
 
SB efforts by MV patients during volume controlled ventilation will alter airway pressures 
and affect identified respiratory mechanics. In this study, it was observed that all patients 
exhibit different levels of rate and severity of SB affected breaths, despite being sedated and 
ventilated in a fully controlled ventilation mode. When M-waves occur, the AUC Edrs is 
reduced since the same volume is delivered for apparently less input air pressure, thus 
reducing observed, but not physiological, pulmonary elastance (Figure 8.5). AUC Edrs rises to 
a consistent value reflecting the true, underlying passive respiratory mechanics when fully-
sedated airway pressure waveforms resume.  
 
These results suggested that the variance in AUC Edrs can be used to determine the presence 
of SB efforts. Since it is not clinically desirable to use additional invasive measuring tools or 
induce further sedation to suppress patient muscle activity (Kress et al. 2000; Ostermann et 
al. 2000), a method is required to re-construct the M-wave airway pressure to approximate a 
normal breath. In this proof of concept analysis, a reconstruction method is introduced and 
compared with the unreconstructed pressure, as in Figures 8.6-8.9. The goal is to estimate the 
true underlying mechanical properties, which might be expected to be relatively constant over 
a short period or at a set PEEP level, as seen in sedated patients (Chiew et al. 2011; Chiew et 
al. 2015). 
 
Figure 8.6 shows a specific example of two breaths, where one would expect the underlying 
respiratory mechanics to be very similar. However, directly solving Equation 8.3 yielded very 
different results for Edrs, despite the lack of change assumed in the patient’s pulmonary 
physiology. Using the reconstruction method, the Edrs curve for the M-wave breaths have 
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almost the same shape as the normal wave, and thus the AUC Edrs for the reconstructed and 
SB-free pressure wave have almost the same area. These results show how a very simple 
reconstruction method can be used to accurately estimate the underlying lung mechanics, 
despite SB efforts.  
 
M-wave affected airway pressure was observed in more than 50% of the total breathing 
cycles for both PEEP levels in Patient 1 (34/62, Table 8.2). It can be seen that most 
reconstructed airway pressure waveforms have approximately the same height and area, 
resulting in a more consistent estimation of the AUC Edrs, and thus the underlying respiratory 
mechanics, as seen in Figure 8.8. The RCV of AUC Edrs for Patient 1 is higher for 
unreconstructed waveforms with RCV= 0.14 at both PEEP 15 cmH2O and PEEP 17 cmH2O, 
compared to the reconstruction method with RCV = 0.08 at PEEP = 15 cmH2O and RCV = 
0.05 at PEEP = 17 cmH2O. Thus, the reconstruction method yields the expected, more 
constant value of AUC Edrs due to greater reconstruction or restoration of the pressure “lost” 
to SB efforts as compared to unreconstructed cases.  
 
Using the reconstructed airway pressure, the area of missing pressure (A2) due to patient 
induced SB effort can be calculated. In particular, it carries breath-specific SB effort that 
cannot be quantified without the use of invasive oesophageal pressure measurements (Benditt 
2005; Khirani et al. 2010; Talmor et al. 2006). Overall, as A2 increases, it indicates increased 
SB effort, as A2 is directly proportional to SB effort as shown in Equation 8.9. Hence, A2 can 
be used as a surrogate of the magnitude of SB.  
 
This value also has potential clinical benefit as it could be used to guide clinicians in real 
time to improve patient-ventilator interaction. A second use would be deciding whether to 
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extubate or re-sedate the patient. These decisions are otherwise clinically difficult and 
variable, and thus much more subjective decisions in clinical practise, which can lead to 
greater variability in care.  
 
Patients 2-5 exhibit relatively minor SB efforts compared to Patient 1 (Table 8.2). This lower 
incidence of SB effort results in a lower missing area (A2) in those patients. Patients 2-5 have 
more consistent breathing, more consistent pressure waveforms, and a lower rate of M-waves 
compared to Patient 1 for the sections of data used. Thus, the AUC Edrs of reconstructed 
airway is almost equal to AUC Edrs of the unreconstructed airway. For example, this outcome 
can be seen in Table 8.2 with the RCV values of unreconstructed pressure for Patient 5 is 
similar to the RCV values of reconstructed pressure across all PEEP levels. Hence, these 
results show that the reconstruction method is robust when there is a relative lack of SB 
effort.  
 
These results also show how reverse triggering occurs randomly and not all patients exhibit 
similar rates or levels. The reconstruction method does not negatively affect the outcomes for 
patients that do not have significant SB efforts. Hence, the process could be safely embedded 
within algorithms that track pulmonary elastance without the need for a secondary algorithm 
to diagnose SB effort prior to implementation. Moreover, pressure reconstruction inevitably 
leads to higher pressure for the affected M-wave, as seen in Figure 8.7. The reconstruction 
ultimately leads to a PV curve that provides a better fit to PV curves for breaths that are 
unaffected by SB efforts. This result shows how this simple pressure reconstruction is able to 
provide a reasonable estimate of the pressure wave that could be expected in the absence of 
SB effort.  
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Figure 8.10 shows the distribution data of % of SB effort against the % of WOBSB which 
leads to a highly correlated value with R = 0.94 across all patients. This result elucidates a 
trend between the % SB effort and % WOBSB. The trend indicates that by implementing the 
pressure reconstruction method, SB effort and the WOBSB of MV patient can be determined 
without having to use invasive sensors or procedures, and without having to interrupt care.  
 
8.5 Limitations  
 
Although the reconstructed airway pressure can estimate the elastance for a spontaneously 
breathing patient, there are limitations to its predictive capability. In particular, SB can occur 
at any time during MV, and the variation of M-waves may differ depending on the ventilation 
mode. This proof of concept study is thus, a first step to explore the possibility of this type of 
very simple reconstruction method, which could be expanded to other ventilation modes as 
desired. Thus, more patient data are required to show the full robustness of the reconstruction 
method. However, this small data set of patients approach was sensible to test the method and 
exhibit the potential benefit in M-wave analysis in SB patients.  
 
Conversely, the latter results imply the importance of measuring SB effort to potentially 
provide clinicians with an indicator to fine tune ventilator for better patient-ventilator 
interaction or weaning process. The weaning process is a critical phase in respiratory therapy 
and a difficult clinical decision (Boles et al. 2007; Esteban et al. 1994). Recent studies have 
shown that MV patients who have the ability to breath by themselves have a higher chance of 
recovery and higher success rate in weaning (Kogler 2009; Marini 2011; Putensen et al. 
1999). Thus, this simple reconstructed airway pressure and proof of concept analysis could 
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open up new options in deciding the optimal, or at very least, consistent, patient condition to 
extubate or re-sedate the patient, which is crucial in MV therapy.  
 
8.5 Summary 
 
This proof of concept study presents a novel, computationally simple method to reconstruct 
airway pressure to better estimate respiratory mechanics and quantify the level of patient-
specific SB effort at every breath. This simple reconstruction method is easy to implement 
without requiring additional sedation or intense clinical protocols, and is computationally 
simple enough for real-time implementation. This method reduces variability in estimated 
mechanical properties that arise from patient-specific SB efforts, and do not represent 
variability in the underlying lung mechanics. Clinically, this method could have impact in 
guiding MV and provide unique information that can potentially be used for clinicians in 
deciding the optimal ventilator settings and improve patient’s condition. 
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CHAPTER 9 
Conclusion 
 
This thesis developed and validated model-based and patient-specific methods for assessing 
lung mechanics that provide further insight into lung mechanics of mechanically ventilated 
(MV) Acute Respiratory Distress Syndrome (ARDS) patients. Four unique models are 
developed based on physiologically relevant and mechanically accurate components using 
clinical data that are able to describe patient-specific conditions and could be used to guide 
MV therapy. These models and validation provides a foundation on which model-based MV 
can be created and clinically implemented. 
 
In Chapter 2, a well-known model-based method, the dynostatic algorithm (DSA), is applied 
to estimate the alveolar pressure of the lung based on the dynostatic curve by using the 
retrospective clinical data. The estimated alveoli pressure is based on assumption that airway 
resistance is always the same during inspiration and expiration at isovolume. The estimation 
of alveolar pressure allows insight into the lung condition and prevents the lung from over-
stretched due to the higher PEEP that applied during MV therapy.  
 
Chapter 3 presents a novel model based method patient-specific airway branching model 
(ABMps) based on individual physiological measurement by using a classical simple 
Poiseuille flow and minor loss equations. The ABMps was applied to retrospective clinical 
data and showed how to estimate the airway pressure drop at each bronchial generation using 
patient-specific physiological measurement. This model can be generated from data measured 
at the bedside with the extension to a patient-specific airway dimension, α. The α value 
relates to the patient condition, where, for example, it was found in Chronic Obstructive 
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Pulmonary Disease (COPD) patients that α ranges from 0.45 – 0.62, which relates to the 
smaller effective diameter of the airways that result mathematically from the lung blockage 
that occurs in COPD. In this chapter, the results of ABMps are compared with the well-
accepted DSA by using the same retrospective clinical data. Results show that it is able to 
capture similar alveolar pressure as the DSA while providing significant further insight into 
patient-specific airway dimensions and patient condition. Hence, the ABMps offers 
significant potential to guide clinicians in setting an optimal MV, is non-invasive, and can be 
personalized. 
 
Chapter 5 extends the investigation on the relation of the parameter K in the expiratory time 
constant model with respiratory system elastance by using data from the expiration breathing 
cycle of ARDS patients. The model used retrospective clinical data from two different 
cohorts to identify the variation of respiratory elastance and parameter K in response to 
different PEEP levels. It was found that significant variation in lung resistance leads to a poor 
correlation between K and respiratory system elastance.  However, K has delivered a good 
indicator for COPD patients. Thus, K has potential in tracking the changes in disease state for 
MV patients in real-time, and could be directly used with COPD patients now. 
  
Chapter 6 focused on quantifying the variability of dynamic respiratory (Edrs) elastance in 
ARDS patients using a time-varying elastance model. To investigate the variability of 
respiratory elastance, clinical data from ARDS patients who underwent a specific clinical 
protocol were used. The area under the curve of Edrs (AUC Edrs) is estimated and analysed 
based on ventilation days, PEEP levels and breath to breath variability. It was found that due 
to patient-specific breathing effort, it produced a negative elastance resulting in increased 
variability in Edrs. Equally, monitoring the variability of Edrs can highlight for clinicians the 
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presence of moderate and smaller spontaneous breathing (SB) efforts in MV patients leading 
to adjustments in care. Furthermore, with the information on elastance variability, it could 
guide clinicians in managing PEEP titration for MV patients.  
 
Due to the SB efforts that occurred in MV patients, it is essential to develop a non-invasive 
model that is able to monitor the respiratory mechanics of SB patients. These SB patients 
modify their airway pressure and flow due to their own, variable, inspiratory effort. As 
mentioned in Chapter 6, the variability of lung elastance happened due to the negative 
elastance that causes by the SB effort. Thus, Chapter 7 reviews the distribution of negative 
elastance of SB patients by using a non-invasive time-varying elastance model. The resulting 
metrics of negative elastance due to SB effort provides an indicator, capable of providing 
unique information to guide MV for spontaneously breathing patients, who make up an 
increasing number of MV patients. 
 
Finally, Chapter 8 presents an airway pressure reconstruction method that is able to 
reconstruct the missing pressure that was due to the SB effort. The missing area of the 
measured airway pressure is hypothesized to be a surrogate of the patient-specific and breath-
specific inspiratory effort, which can be used to assess the strength of SB efforts. By using 
the clinical data from ARDS patients, this simple pressure reconstruction method has 
demonstrated that it is able to deliver with a quality clinical metric that able to measure the 
respiratory system properties of a SB patient and measure the surrogate of the SB effort, that 
latter can be useful for clinicians in deciding whether to extubate or re-sedate the patient.  
 
Overall, the patient-specific models and metrics presented in this thesis provide unique 
capability in providing new clinical insight into patient-specific and even breath-specific lung 
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condition and patient-specific response to MV settings. The models have been tested using 
clinical data from different cohorts and have shown promising results that will be useful in 
guiding MV decision making in an ICU for both fully sedated and SB patients. Thus, the 
modelling approach discussed in this thesis shows great potential to be used as the foundation 
for clinical decision support tool for managing and optimizing patient-specific MV setting. 
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CHAPTER 10 
Future Work 
 
The models and metrics presented in this thesis have created a good platform to deliver 
optimized ventilation therapy for ARDS patients. However, further optimization and 
extensive clinical study can, and should, be implemented to fully validate the ability of these 
models and the robustness of the system.  
 
10.1 Additional Monitoring Tools for Model Validation 
 
In this thesis, the models and metrics developed have presented clinical potential to guide 
optimal MV setting. However, validation of the clinical relevance and physiological insight 
of a model-based approach is currently limited. Specifically, the ABMps model could capture 
patient-specific airway pressure changes and unique patient-specific clinical information 
(Damanhuri et al. 2014). However, the current findings warrant further investigation. Thus, it 
would be a significant advantage to have additional lung imaging methods such as Computed 
Tomography (CT) scans, to provide better information and physiological insight on the 
airway branching and bifurcations on each patient. With these measurements, the models can 
be further and better validated, and this level of validation would more strongly encourage 
and support the model’s clinical application to guide MV. 
 
Furthermore, additional monitoring tools, such as in-vivo microscopy, Electrical Impedance 
Tomography (EIT) (Denai et al. 2010; Zhao et al. 2010b) and lung ultrasound (Bouhemad et 
al. 2007; Peris et al. 2010), allows the recruitment of collapsed of lung units to be directly 
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observed in real-time. Hence, with the results from the models and methods developed will 
have their predictive capability and clinical potential directly validated by clinically well-
accepted, more direct, but invasive measurements.  
 
10.2 Clinical Protocol and Data Collection 
 
Further investigation and validation could also be applied to the expiratory time constant 
model using the CURE clinical data. Previously, van Drunen et al. (van Drunen et al. 2013) 
studied the model based on animal data only. Based on results in Chapter 5, the model using 
human data showed different results for the correlation between the expiratory time constant, 
(𝐾) and lung elastance, (𝐸𝑟𝑠) for two different cohorts. Thus, by using a standard clinical 
protocol, the larger clinical cohort may provide more consistency in results between K and 
𝐸𝑟𝑠 and settle this discrepancy. To investigate the expiratory time constant model further, a 
clinical protocol could be designed where the tidal volume (𝑉𝑡) is varied between low and 
higher values at a constant PEEP.  
 
In addition, recruiting more ARDS patients for clinical trials remains the main focus for 
model-based studies. A non-invasive clinical protocol that is suitable for data collection has 
been put forward in Chapter 6. This protocol has several unique features that are designed for 
this purpose.  
 
In particular, this thesis has discussed that SB effort can occur at any time during MV, which 
has been explained in Chapter 8. The airway pressure reconstruction is able to estimate the 
respiratory mechanics of SB patients. However, the variation application of SB efforts may 
differ depending on clinical protocol and ventilation mode. Thus, a standard protocol that 
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specifically designed to monitor SB effort would be of significant utility. With more SB 
patient data, it can show the full robustness of the airway reconstruction method.  
 
Protocol standardisation will not only improve data sample size, the significant data samples 
can indirectly lead to a development of a virtual patient database. This database will lead to 
more comprehensive study in model-based MV. It may also provide further clinical or 
physiological insight via machine learning or other modelling and/or analytics.   
 
10.3 COPD patients  
 
The patient-specific ABM model (ABMps) (Damanhuri et al. 2014) has shown its capability 
for assessing airway pressure drops in ARDS patients with the specific airway dimension, 𝛼 
that relates to patients disease state. The results presented in this thesis found that patients 
suffering from COPD had smaller effective diameter for these physiological measurements 
compared to other ARDS patients, as discussed in Chapter 3. Furthermore, it also showed in 
Chapter 5 that COPD patients have higher airway resistance due the smaller effective 
diameter of the lung branches because the airway blockages in COPD increase airway 
pressure drop in the lung. Thus, larger cohorts consisting of COPD patients may provide 
more significant results that are potentially useful in diagnosing and providing further insight 
into lung condition in COPD patients.  
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